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In South Africa young women bear a disproportionate burden of HIV infection however, risk 
factors for HIV acquisition are not fully understood in this setting. In a cohort of 245 HIV 
negative women, we used proportional hazard regression analysis to examine the association 
of demographic, clinical and behavioural characteristics with HIV acquisition. The overall 
HIV incidence rate (IR) was 7.20 per 100 women years (wy), 95% Confidence Interval (CI) 
4.20–9.80]. Women 18 to 24 years had the highest HIV incidence [IR 13.20 per 100 wy, 95% 
CI 6.59–23.62] and were almost three times more likely to acquire HIV compared to women 
25 years and older [adjusted Hazard Ratio (aHR) 2.61, 95% CI 1.05–6.47]. Similarly, women 
in relationships with multiple sex partners [IR 8.97 per 100 wy, 95% CI 5.40–14.0] had more 
than twice the risk of acquiring HIV when compared to women who had no partner or who 
had a husband or stable partner (aHR 2.47, 95% CI 0.98–6.26). HIV prevention programmes 





This dissertation represents original work, supervised by Professors Ayesha BM Kharsany 
and Salim S Abdool Karim and is submitted in partial fulfilment of the requirements of 
Master of Public Health degree. The dissertation is based on a secondary analysis of data 
collected in the CAPRISA 002 Study (Viral Set Point and Clinical Progression in HIV-1 
subtype C infection: The role of immunological and viral factors during acute and early 
infection). No participant contact was required for the analysis undertaken in this dissertation.  
 
 















I, Nivashnee Naicker, declare that: 
This Master of Public Health dissertation is my own work and all primary and secondary 
sources have been appropriately acknowledged. The dissertation has not been submitted to 
any other institution as part of an academic qualification. 
 
This dissertation is in partial fulfilment of the requirement of the Master of Public Health 
degree at the School of Family and Public Health Medicine, Nelson R Mandela School of 
Medicine, University of KwaZulu-Natal, Durban South Africa. 
  
 




Permissions and Ethics Approval  
The CAPRISA 002 Study protocol was reviewed and approved by the ethics committees of 
the University of Natal (E013/04), University of Cape Town (025/2004) and University of the 
Witwatersrand (MM040202). Ethics approval for a secondary analysis of data was granted 
from the Biomedical Research Ethics Committee, University of KwaZulu-Natal (BE 092/11) 
and permission to review data stored in the CAPRISA 002 database was approved through 




I would like to dedicate this work to my parents Shan and Prem Naicker. Through your hard 
work and personal sacrifices I have been able to realise my dreams. I am forever indebted to 
you.  
 
And to God almighty, for making everything possible. 
vi 
 
Publications or Presentations 
A conference abstract entitled ‘Predictors of HIV Acquisition in High Risk Women in 
Durban, South Africa’ was presented at the 6th South African AIDS Conference, Durban 
ICC, 18th – 21st June 2013 as a poster presentation. 
 
The manuscript entitled ‘Risk Factors for HIV Acquisition in High Risk Women in a 
Generalised Epidemic Setting’ was accepted for publication by the journal AIDS and 
Behavior on 10 January 2015 (reference AIBE-D-14-00551R2) and was published online on 
11 February 2015.  
vii 
 
Acronyms and Abbreviations 
 
AIDS Acquired Immune Deficiency Syndrome 
ART Antiretroviral treatment 
CAPRISA 
CCR5 
Centre for the AIDS Programme of Research in South Africa 








Human Immunodeficiency Virus 




Herpes simplex virus 
Human Sciences Research Council 
IRR Incidence Rate Ratio 
KZN KwaZulu-Natal 
OR Odds Ratio 









My sincere gratitude to my supervisor Professor Ayesha Kharsany for your guidance and 
mentorship over the past three years. Your patience, kindness and encouragement have made 
this project an enjoyable experience for me. I am forever grateful for the knowledge you have 
imparted to me and I hope to continue learning from you in future. 
 
Thank you to my co-supervisor Professor Salim Abdool Karim, for your guidance and 
support during my course of study and for all the years I have been at CAPRISA. You are an 
inspiration to me and to a whole generation of researchers.  
Professor Abdool Karim is the Principal Investigator of the CAPRISA 002 study. 
 
My heartfelt gratitude to the CAPRISA 002 team, of which I have been a part of since 2008. 
Your dedication and commitment to the study and to the participants is unparalleled.  
 
A special thanks to the CAPRISA 002 research participants, without whom this study would 
not have been possible. 
 
This study was made possible through the funding support from CAPRISA. CAPRISA was 
established as part of the Comprehensive International Program of Research on AIDS 
(CIPRA) of the Division of AIDS (DAIDS), National Institute of Allergy and infectious 
ix 
 
Disease (NIAID), National Institutes of Health (NIH), US Department of Health and Human 
Services (DHHS) [grant number 5U19 AI051794].  
 
Special thanks to the following people:  
 
Ms Lise Werner, for your patience and guidance with the statistical support of this project. 
This work would not have been possible without your assistance. 
Ms Werner is the statistician on the CAPRISA 002 study. 
 
Dr Nigel Garrett, for your support and encouragement on a daily basis and for your guidance 
on the clinical aspects of this project. Dr Garrett is the current Project Director of the 
CAPRISA 002 Study. 
 
Professor Koleka Mlisana, for your leadership as previous Project Director on the CAPRISA 
002 study. Thank you for being a great mentor and for nurturing my interest in research 
during your time at CAPRISA.  
 
Dr Francois van Loggerenberg, for your assistance with this project. Dr van Loggerenberg 
worked as Study Coordinator on the CAPRISA 002 study previously and was responsible for 
establishing the original CAPRISA 002 cohort.   
x 
 
To my husband Eugene, thank you for allowing me the opportunity to pursue my dreams and 
for your love and support during this journey. 
 
To my daughter Hridaya, you have filled my life with immeasurable joy and happiness since 
the day you were born. I am truly blessed to have you.  
xi 
 
Table of Contents 
Abstract ....................................................................................................................................... i 
Preface........................................................................................................................................ ii 
Declaration ............................................................................................................................... iii 
Permissions and Ethics Approval ............................................................................................. iv 
Dedication .................................................................................................................................. v 
Publications or Presentations .................................................................................................... vi 
Acronyms and Abbreviations .................................................................................................. vii 
Acknowledgements ................................................................................................................ viii 
Table of Contents ...................................................................................................................... xi 
List of Tables ........................................................................................................................... xii 
List of Figures ........................................................................................................................ xiii 
Chapter 1: Introduction .............................................................................................................. 1 
Chapter 2: Literature Review ..................................................................................................... 2 
Chapter 3: Journal Manuscript ................................................................................................. 31 
Chapter 4: Discussion .............................................................................................................. 63 
Chapter 5: Conclusion and Implications for Future Research and Policy ............................... 68 
Chapter 6: References .............................................................................................................. 70 
Chapter 7: Appendices ............................................................................................................. 90 
1. Study Protocol ...................................................................................................................... 91 
2. Approvals from the Postgraduate Education and Research Committee and Biomedical 
Research Ethics Committee ..................................................................................................... 92 
3. CAPRISA 002 Study Participant Information Leaflet......................................................... 93 
4. CAPRISA 002 Study Informed Consent Documents .......................................................... 94 
5. CAPRISA 002 Study Risk Behaviour Assessment Questionnaire ...................................... 95 




List of Tables 
 
Table I Baseline socio–demographic, behavioural and biological characteristics 
of women, overall and by HIV status, Durban, South Africa, 2004/2007 
 
 
Table II Socio–demographic, behavioural and biological risk factors for HIV 





List of Figures  
 
 
Figure 1 HIV testing algorithm. ELISA, Enzyme-linked immunosorbent assay; 
PCR, polymerase chain reaction 




Chapter 1: Introduction 
 
The Human Immunodeficiency Virus (HIV) epidemic remains one of the greatest public 
health challenges of the 21st century. The discovery of the disease in 1981, among young 
homosexual men presenting with atypical pneumonia in North America, led to the global 
spread of HIV (1). To date, an estimated 75 million infections resulting in 36 million deaths 
have occurred globally. HIV is the third leading cause of deaths worldwide (2, 3). Recent 
advances in the provision and scale up of antiretroviral treatment (ART) has transformed this 
previously fatal disease to that of a chronic manageable condition, substantially reducing 
morbidity and mortality (4).  
 
Despite the availability of ART, the majority of new HIV infections occur in sub-Saharan 
Africa (SSA) with SSA bearing the greatest global burden of HIV (4). Within SSA, southern 
Africa, including South Africa, has been disproportionately burdened by the epidemic with 
sustained high HIV prevalence and incidence rates particularly in women (5, 6). Risk for HIV 
acquisition in high HIV burden settings has been attributed to a combination of structural, 
socio-demographic, behavioural and biological factors, however, better understanding these 
factors could be used to design interventions to shape behaviour and reduce vulnerability and 
risk of HIV.  
 
The overall aim of this research was to assess risk factors for HIV acquisition in a cohort of 
high risk women, comprising female sex-workers and women with at least three sexual 
partners, in Durban, KwaZulu-Natal; with a focus on behavioural, biological and socio-
demographic characteristics.  
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Chapter 2: Literature Review 
 
The purpose of the literature review is to explore current evidence relating to the research 
topic ‘Predictors of HIV acquisition in high risk women in Durban, South Africa’ in 
order to provide baseline information on the subject which may be used to compare and 
contrast findings of this study with other studies undertaken locally and in other regions. 
The following literature review provides an overview of HIV epidemiology and factors 
contributing to the HIV epidemic and explores in-depth risk factors at the individual level 
which are associated with HIV infection. These include socio-demographic, behavioural and 
biological factors. 
A computerized search of PubMed and Medline databases was done using the key words 
‘HIV’, ‘risk’ and the subheading of interest eg. ‘pregnancy’. Google Scholar searches and 
references from relevant articles were also used. Studies were limited to those published in 
English from 1985 to present. 
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1. HIV Epidemiology 
1.1. The Global Epidemiology of HIV 
At the end of 2012, an estimated 35.3 million people were living with HIV globally (7). The 
distribution of the HIV epidemic varies between continents, regions, countries and even 
within countries. Sub-Saharan Africa remains the worst afflicted region contributing 
approximately 70% of all HIV infections worldwide yet accounting for only 12% of the 
world’s population (7, 8). In this region, women are disproportionately burdened by the 
disease, comprising almost 60% of adults living with HIV (8). Within SSA, southern Africa 
remains the worst affected region contributing over a third of global HIV infections and 40% 
of infections are in women (8). Other regions heavily burdened by the epidemic include 
Eastern Europe, Central Asia, South and South-East Asia, Latin America and North America 
(7). 
Recent trends have shown a decline in new HIV infections globally by 33% since 2001 due to 
a scale up of HIV prevention and treatment efforts and the natural course of the epidemic, 
however variations in trends exist (7, 8). While SSA has experienced a 34% decline in new 
infections between 2001 and 2012, in almost half the countries in the region, areas such as the 
Middle East, North Africa, Eastern Europe and Central Asia have experienced an increase in 
the number of new infections during the same period (7, 8).  
With the expansion of antiretroviral treatment (ART) programmes globally, a greater number 
of people are now living with HIV. An estimated 5.5 million deaths related to Acquired 
Immune Deficiency Syndrome (AIDS) have been averted in low and middle income 
countries and life expectancy has significantly increased (7). Fewer children have acquired 
HIV due to the provision of antiretroviral chemoprophylaxis to pregnant women for the 
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prevention of mother to child transmission of HIV, the greatest benefit of which has been 
seen in SSA (8). However, regions such as Eastern Europe, Central and East Asia, the Middle 
East, North Africa have experienced an increase in AIDS-related deaths between 2001 and 
2010 (8). Furthermore, despite the substantial gains made in SSA over the past decade, 70% 
of all new infections among adults and children occurred in SSA in 2012 (7).   
1.2. Transmission of HIV  
Sexual transmission is the predominant route of HIV transmission, accounting for 
approximately 80% of all infections globally (4). Sex acts between heterosexual couples 
discordant for HIV infection, where one partner is HIV positive and the other is HIV 
negative,  perpetuates the epidemic in regions such as SSA and the Caribbean, and among 
men who have sex with men (MSM), in Latin America and North America (8). Injection drug 
use, common in Asia and Eastern Europe, contributes to about 10% of infections globally and 
is becoming increasingly more common in SSA (4, 8). Approximately 6% of HIV 
transmission occurs through vertical transmission from mother to child during the antepartum 
period, intrapartum period or through breastfeeding in the postpartum period (4). A high-level 
of ART coverage for prevention of mother-to-child transmission has seen significant declines 
in the number of children newly infected with HIV in the last decade (7). Transmission 
through blood and other infected bodily fluids accounts for the remaining 4% of infections 
which occur in healthcare settings (4). 
1.3. HIV Epidemic Typologies 
HIV epidemic typologies may be described as low-level, concentrated or generalised 
epidemics (4). In low-level epidemics, HIV may be present for a long period but never 
reaches significantly elevated levels in the population (4). The HIV prevalence remains 
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between 1% and 5% in the general population (4). West Africa is an example of a region with 
a low-level epidemic (4). Concentrated epidemics are characterised by high rates of HIV 
within specific subgroups such as MSM, injection drug users or sex workers (4). In this type 
of epidemic, HIV is not well established in the general population (4). HIV prevalence is 
above 5% in these at risk populations and this may vary between countries (9). North 
America, Canada, South America and China are some of the countries characterised by this 
epidemic typology (9). Most countries in SSA are experiencing a generalised epidemic where 
HIV is firmly established in the general population with prevalence exceeding 5% in adults 
(4). Heterosexual transmission is the main mode of transmission. Southern Africa which is 
the worst affected region in SSA, is considered to be the epicentre of the HIV epidemic and 
accounts for 40% of all women infected with HIV globally (8). This region is characterised 
by a hyperendemic generalised epidemic with HIV prevalence exceeding 15% in the adult 
population (4). Countries affected include Swaziland, Botswana, Lesotho, Mozambique, 
South Africa, Zambia, Zimbabwe and Malawi (4). HIV transmission in the SSA region is 
predominantly heterosexual and young women remain at high risk of HIV, acquiring 
infection five to seven years earlier than males with three to six times higher rates of infection 
(10). 
1.4. Monitoring the HIV epidemic 
HIV prevalence is a useful measure of existing HIV infections in a population. Increasing 
HIV prevalence in a population signifies increased survival rates, mainly due to effective 
antiretroviral treatment which leads to reduced morbidity and mortality. HIV incidence is a 
more sensitive measure to monitor the epidemic, indicating the rates of new infections arising 
in a population. It is a useful tool to gauge the rate of HIV transmission and changes in HIV 
incidence over time may be used to evaluate the impact of prevention measures on the HIV 
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epidemic. HIV incidence may be measured directly by longitudinal follow up of at-risk 
persons through prospective cohort studies (11). However, some of the limitations of 
prospective cohort studies are that they are logistically difficult to implement and prone to 
biases due to the sample selected, changes in behaviour in subjects due to repeat HIV testing 
and losses to follow up over time (11). Furthermore they are costly to undertake. Another 
method of measuring HIV incidence is through indirect measurement using HIV prevalence 
and mortality data in a population, however this method is also subject to limitations 
regarding the availability of  reliable prevalence data (11). A third method of measuring HIV 
incidence is through the use of laboratory-based assays which distinguish recent from 
established HIV infection in cross-sectional surveys however misclassification of established 
HIV infection as recent infect remains a drawback (11). In developing countries, a 
combination of the above methods are used to measure HIV incidence, depending on the 
availability of resources.   
1.5. HIV Epidemiology in South Africa 
South Africa’s HIV epidemic is the largest in the world, with an estimated 6.1 million people 
living with HIV in 2012 (7). PMTCT roll-out using single dose nevirapine was first initiated 
in late 2002 followed by wide-scale ART roll-out in 2004 (12). South Africa has one of the 
largest ART programmes in the world which has led to a concomitant decline in AIDS 
related morbidity and mortality. Between 2001 and 2012, new HIV infections among adults 
15 years and older was estimated to decline by 63% (7). Despite the substantial gains made 
with HIV prevention programmes and ART provision in the past decade, young women 
continue to be at high risk of HIV in this setting (6, 13, 14). 
Antenatal HIV prevalence data are a useful tool to monitor the epidemic trajectory and 
burden of disease. The national antenatal HIV prevalence was 29.5% [95% Confidence 
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Interval (CI) 28.8-30.2%] in 2012 (5). The provinces of KwaZulu-Natal (KZN), Mpumalanga 
and Free State experience higher rates of infection, and among women aged 15 to 49 years, 
the HIV prevalence in these three provinces exceeded 30% in 2012 in contrast to the Western 
Cape which had a lower  prevalence of 16.9% (95% CI 13.8-20.5%) (5, 15). 
Among young pregnant women, in the 15 to 24 year age group, the overall HIV prevalence 
was 20.1% (95% CI 19.5-20.8%) in 2011 and 19.3% (95% CI 18.7-19.9) in 2012 (5). The 
HIV prevalence in the 15 to 24 year age group is recognised as a reliable proxy measure for 
HIV incidence, as infections in young people represent new infections (16). Despite the high 
HIV prevalence reported among young pregnant women, national population based surveys 
such as the South African National HIV Prevalence, Incidence and Behaviour Survey 
undertaken by the Human Sciences Research Council (HSRC) indicated a 60% reduction in 
HIV incidence among 15 to 24 year old women between 2002 and 2008 (17, 18). 
Notwithstanding these reported declines, HIV incidence among young women remains 
unacceptably high (6, 13). 
Given the high burden of HIV in this setting, particularly among women, it is important to 
examine the contributing factors which may determine susceptibility to HIV. These may be 
broadly categorised as structural factors and, at the host level, the socio-demographic, 




2. Structural Factors Contributing to HIV Risk 
Structural factors may be considered to be the physical, social, cultural, organisational, 
community, economic, legal or policy aspects of the environment which facilitate HIV 
transmission (19). These factors influence behaviour at the individual level and the 
association between structural factors and HIV risk is complex and direct causality is not 
always easy to establish (19).  
Social aspects include but are not limited to population mobility, gender discrimination and 
gender violence, racism and segregation, and social marginalisation of vulnerable populations 
(19, 20). Globally, mobile populations bear a greater risk of HIV infection (20). Population 
mobility may be due to labour migration, as seen in South Africa, refugee migration, internal 
migration, resettlement or commuting (20). Drug trade and long distance truck routes have 
also contributed to the spread of HIV in countries such as India, South America, Asia and 
Africa (20, 21). Gender discrimination leading to economic disempowerment, sexual 
violence and overall diminished rights for women all contribute to HIV risk. Racial 
discrimination and segregation are implicated in HIV risk. In North America, African 
Americans have the highest HIV incidence, contributing to 44% of all new infections in 2010 
despite accounting for only 12% of the population (22). Vulnerable populations, which 
include people with disabilities, remain at increased risk of HIV due to social 
marginalisation. The 2012 HSRC survey conducted in South Africa found that people with 
disabilities had a reported HIV prevalence of 16.7% (95% CI 12.9-21.4), higher than the 
national prevalence of 12.2% (95% CI 11.4 – 13.1) (18). 
Economic policy and income at a national level are also thought to impact HIV risk since the 
majority of global infections occur in SSA where most countries are low-income countries. 
However, a study exploring per capita income of African countries and HIV risk found no 
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association (23). Instead middle-income countries including South Africa are known to have 
higher prevalence of HIV (23). Economic policy relating to resource allocation to healthcare 
particularly for HIV and AIDS also impacts risk. In countries like Uganda increased resource 
allocation for HIV and AIDS and high level political commitment has led to a dramatic 
decline in new infections (24). National policy regarding housing and sanitation, education, 
income, social organisation and law enforcement continue to impact HIV risk. Specific laws 
relating to sex work, illicit drug use and the criminalisation of HIV also impact HIV risk at a 
structural level (20).  
The differences in HIV prevalence amongst women in low to middle-income and high-
income countries highlight the stark disparities across regions and countries (8, 25). 
Structural approaches which seek to change an individual’s social, economic and political 
environment are recognised as an integral component of HIV policy in order to support 
current behavioural and biomedical prevention strategies if these are to be successful in the 




3. Risk Factors at the Individual Level 
3.1. Socio-demographic Risk Factors 
Socio-demographic factors at the individual level are interrelated to structural factors which 
define an individual’s environment. As opposed to structural factors, these factors are 
considered to be proximal to the individual thereby impacting HIV risk directly (19). Some of 
these factors include age, race, marital status, employment status or household income, level 
of education, living conditions or place of residence (18, 26, 27).  
In South Africa, inequalities especially in education, access to health care, housing and 
employment are common due to the country’s political history and the Black African race 
group remain the most disadvantaged population. This race group is also the worst afflicted 
by the epidemic as shown in the 2012 HSRC survey in which the prevalence of HIV among 
Black Africans was 15% (95% CI 14.0-15.9%), followed by Coloureds with a prevalence of 
3.1% (95% CI 2.2-4.2) (18). The HIV prevalence among Asian and White population groups 
was less than 1% (18). As poverty is rife in South Africa, with the proportion unemployed at 
25.4%, labour migration and urbanisation is common in this setting (28). Studies within 
South Africa have shown that migrant men and women as well as residents of urban informal 
settlements are at increased risk for HIV (15, 29-31). 
At the individual level, the evidence regarding income level or employment status and HIV 
risk is less clear. A review of 36 studies investigating the impact of socio-economic status of 
women in SSA found no conclusive link between low socio-economic status and HIV risk 
(26). The authors concluded that HIV risk may initially rise with increased access to 
resources for women in low income countries while in countries with higher per capita 
income, increasing socio-economic status of women may reduce risk for HIV (26). Socio-
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economic variables in the study included educational level, household income and 
employment (26). In South Africa, a large population based study which included men and 
women conducted in rural KwaZulu-Natal found that individuals in middle-income 
households were at increased risk for HIV as compared to those in the poorest households 
[adjusted Hazard Ratio (aHR) 1.86; p=0.002] (32). In this study the effect of educational 
attainment, household wealth and household expenditure on HIV incidence was evaluated 
(32). Among urban women in KwaZulu-Natal, unemployment or having no income was 
found to be a significant risk factor for HIV acquisition [Hazard Ratio (HR) 1.47, 95% CI 
1.02-2.17; p=0.043] (33). These studies suggest that the impact of socio-economic status on 
HIV risk differs across regions and within countries and is influenced by the greater socio-
economic status of the region.  
The association between level of education attained and risk for HIV remains controversial. 
In Cameroon, among women aged 15 to 49 years participating in a national survey, HIV 
prevalence was found to be lowest, at 3.3% among those with no formal education (34). HIV 
prevalence was doubled in women reporting a primary or secondary education (34). Among 
women 18 years or older recruited from post natal or family planning clinics in Malawi and 
Zimbabwe, HIV risk increased with increasing level of education (35). In this study, higher 
HIV incidence correlated with a higher level of education (O-level examinations or higher 
versus none: HR 3.25, 95% CI 1.39–7.57; p=0.006) (35). Contrary to these findings, a 
prospective cohort study in Tanzania, which included men and women older than 18 years, 
found that achieving a secondary education was associated with lower HIV incidence and 
risk for HIV (secondary school versus none: HR 0.39, 95% CI 0.17-0.89; p=0.01) (36). 
However HIV incidence was low in that study at 1.35 per 100 person years (95% CI 1.10-
1.64/100 person years). (36). Similar inconsistent findings are reported from studies in South 
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Africa. In a study in the Free State province found that older women reporting no formal 
education or a primary school education were less likely to be HIV infected (p=0.018) (37). 
In contrast, a national survey of sexually active young women aged 15-24 years, found that 
those who did not finish school were more likely to be HIV positive [adjusted Odds Ratio 
(aOR) 3.75, 95% CI 1.34-10.46] (27). A population based survey in rural KwaZulu-Natal, 
found that every additional year of school education reduced risk for HIV acquisition (aHR 
0.93, p=0.022) (32). Similarly, a study of 18 to 24 year-old men and women from four 
provinces in South Africa found that having a grade 8 (aOR 0.04, 95% CI 0.01-0.66; p<0.05) 
or higher (aOR 0.04, 95% CI 0.01-0.43; p<0.01) education was protective against HIV 
infection (38). Overall, studies which included men, demonstrated a protective effect of 
higher educational level with HIV risk (32, 36, 38). However, in women, in older age groups 
lower educational level was found to be protective and in contrast in young women a higher 
educational level  was  protective suggesting that  HIV acquisition is related to age of women 
(27, 34, 35, 37).  
A relationship status of being married has been shown to considerably reduce the risk of HIV 
acquisition. In the 2012 HSRC survey, HIV incidence was lowest at 0.6% among people who 
were married compared to those who were single (3.4%) and people cohabiting with a sexual 
partner (3.7%) (18). Similar trends are seen in other African countries such as Malawi and 
Zimbabwe, where being unmarried was found to be a risk factor for HIV (35). In Free State 
province, South Africa, HIV uninfected older women were more likely to be married 
(p=0.01) while HIV uninfected women, irrespective of age (p=0.012 for younger women and 
p=0.002 for older women), reported husband headed households more frequently compared 
to HIV infected women (37). In rural KwaZulu-Natal, both men and women who were 
unmarried had twice the risk of acquiring HIV compared to those who were married 
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(p<0.001) (39). In urban KwaZulu-Natal, being single or lack of cohabitation with sexual 
partner was associated with HIV infection (HR 4.76, 95% CI 2.60-8.74; p<0.0001) among 
sexually active women (33). While marriage appears to be protective against HIV, this may 
not hold true for younger women, especially adolescents (40-42). Child and adolescent 
marriages are highly prevalent in developing countries (42). In Uganda, HIV incidence was 
increased among formerly married young women 15 to 24 years of age (40). In the same 
region a decline in adolescent marriage was one of the factors associated with a reduction of 
HIV incidence between 1999 and 2011 (41). Gender imbalances leading to non-consensual 
sex within marriage, partner age disparity within marriage and inability to negotiate condom 
use are some of the reasons why young women may be predisposed to HIV infection within 
marriage (42, 43).  
Several studies have demonstrated that young age is associated with increased risk for HIV 
(33, 36, 44). Studies from SSA indicate that both young men and women are at increased risk 
for HIV (36, 44). In Rwanda, teenage antenatal clinic attendees were at highest risk of HIV 
after two years of follow up (OR 4.8, 95% CI 1.3-18.4) (45). In KwaZulu-Natal, South 
Africa, HIV incidence was highest among women aged less than 20 years among urban 
Sexually Transmitted Infection (STI) clinic attendees (6). Another study of sexually active 
women in urban KwaZulu-Natal found that women aged 24 years or less had more than twice 
the risk of acquiring HIV compared to women aged 35 years and older (HR 2.78, 95% CI 
1.88-4.11; p<0.0001) (33). Similarly, the HSRC survey showed comparable trends with 
24.1% of all new infections accounted for by women aged 15 to 24 years in 2012 (18). 





3.2. Biological Risk Factors 
For biological reasons, the anatomy of the female genital tract and factors which affect the 
genital tract epithelium may place women at increased risk for HIV (46). The stage of HIV 
disease, circulating viral load and ART status of an infected partner also determines HIV risk. 
Other biological factors which may impact HIV risk include host genetic factors, host 
immunity and nutritional status.  
3.2.1. Anatomy, Exposure to Virus and Viral Entry  
Globally, unprotected sexual intercourse between HIV discordant couples is the primary 
mode of HIV transmission. Studies from North America and Europe have shown that male to 
female transmission of HIV is more efficient than female to male transmission (47, 48). This 
may be attributed to anatomical differences, with the female genital tract providing a larger 
surface area for HIV entry (47). The presence of semen in the female genital tract is thought 
to provide a more favourable environment for HIV survival (47). Anal sex is associated with 
increased HIV risk as the rectal mucosa is prone to trauma and like the vagina; may provide a 
greater surface area for viral entry if exposed to infected semen. Receptive anal sex has been 
associated with higher levels of transmission in studies of MSM however insertive anal sex is 
also known to carry risk (49-51). Female sex workers engaging in anal sex were found to be 
at increased risk for HIV acquisition (OR 2.30, 95% CI 1.10-4.70) (52). Oral sex too poses a 
risk for HIV transmission, albeit lower than risk from anal or vaginal sex (53).  
The stage of HIV disease in the infected partner and ART status may also impact risk for 
HIV. Sexual contact with a partner who recently acquired HIV or one who has AIDS is 
associated with increased risk for acquisition due to higher viral load exposure. A study in 
Uganda, found that risk of HIV transmission probability was proportional to the circulating 
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viral load of the infected partner (54). The recent HPTN 052 randomised controlled study 
supported this finding (55). Early initiation of antiretroviral treatment (CD4+ cell counts  
between 350 cells/µl and 550 cells/µl) in HIV infected individuals conferred 96% protection 
against HIV in sex partners compared to those initiating ART at CD4+ cell counts of 250 
cells/ul or less (55). This was attributed to viral suppression in genital secretions by ART 
thereby reducing the viral load and risk to sexual partners (55). 
3.2.2. Factors Affecting the Structure and Integrity of the Genital Tract Epithelium 
As the genital tract mucosa is the first point of viral entry during heterosexual intercourse, 
understanding the factors which affect the integrity of the vaginal epithelial surface is 
paramount to understanding susceptibility to HIV in women. Physiological changes of the 
genital tract, which include cervical ectopy and pregnancy, and other factors such as 
hormonal contraception use, sexually transmitted infections and vaginal insertion practices 
may determine HIV susceptibility at the mucosal level.  
3.2.2.1. Cervical Ectopy 
Cervical ectopy occurs when the columnar epithelium of the cervical endocervix comes to lie 
on the ectocervix (56). It is a common occurrence in young pubescent women as this 
physiological change is due to increased oestrogen levels (56). The degree of ectopy varies 
and changes with age (57). Cervical ectopy is a common occurrence during pregnancy and 
with use of hormonal contraception (56, 58). It is associated with increased risk for STIs such 
as Chlamydia trachomatis, Neisseria gonorrhoeae and herpes simplex virus (HSV) (57). In 
Cape Town, South Africa, women with  cervical ectopy of greater than 20% were at higher 
risk of HIV infection (OR 2.18, 95% CI 1.01-4.69) however, since women aged 35 to 65 
years old were included in the study, it is possible that the exclusion of young women at 
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higher risk for HIV may have biased the study findings (59). In Nairobi, Kenya, cervical 
ectopy was found to be a predictor of HIV among heterosexual women (OR 5.0; p=0.007) 
(60). In a review of observational studies, which included the South African and Kenyan 
study, only four studies, mainly from Kenya found that cervical ectopy was associated with 
HIV acquisition (61). Some of the studies which showed a positive association were 
undertaken in women with concomitant STIs or genital ulceration, making the temporal 
association of cervical ectopy and HIV acquisition less discernible. While this physiological 
change may offer a possible explanation for why young women are at increased risk of HIV 
acquisition, current empiric evidence in the African setting remains limited. 
3.2.2.2. Pregnancy  
Numerous studies have examined the association between pregnancy and the risk for HIV 
acquisition (62-65). The physiological changes in pregnancy, particularly the increase in 
levels of oestrogen and progesterone, are thought to increase susceptibility to HIV by 
inducing changes in the genital tract mucosa (63). Immunologic changes such as upregulation 
of HIV-1 co-receptors and changes in T-cell immunity have also been implicated (63). In 
Kenya HIV risk doubled during pregnancy (HR 2.34, 95% CI 1.33-4.09) although the results 
were not significant after controlling for sexual behaviour and clinical factors (aHR 1.71, 
95% CI 0.93-3.12) (62). In the same study HIV incidence in male sexual partners was more 
than two-fold during pregnancy compared to partners of non-pregnant women suggesting that 
pregnancy may also increase transmission of HIV to male sexual partners (HR 2.31, 95% CI 
1.22-4.39) (62). This finding remained significant in the adjusted analysis (aHR 2.47, 95% CI 
1.26-4.85; p=0.01) (62). In Uganda, a prospective study examining HIV incidence rates 
during pregnancy, found that HIV incidence during pregnancy [Incidence Rate Ratio (IRR) 
2.16, 95% CI 1.39-3.37] was double compared to women who were not pregnant or not 
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breastfeeding (63). This risk was similar (IRR 1.82, 95% CI 1.09–3.05) to women who were 
breastfeeding (63). In a separate prospective study conducted at family planning sites in 
Uganda and Zimbabwe, pregnancy was not associated with increased risk of HIV (64). 
However, HIV incidence and pregnancy rates were low in this study. Furthermore the authors 
acknowledge behavioural and biological differences in the Zimbabwean population which 
may explain the inconsistency with earlier findings from Uganda (63, 64). Notwithstanding, 
the HPTN 039 study showed similar results as pregnancy was not associated with HIV risk in 
HSV-2 seropositive women from Zambia, Zimbabwe and South Africa (65). Pregnancy 
incidence was high in this study. Overall the evidence for increased HIV risk during 
pregnancy is weak and needs to be explored further.  
3.2.2.3. Hormonal Contraception Use 
Hormonal contraception, in particular progesterone preparations, are thought to induce 
changes in the vaginal mucosa which may increase susceptibility to HIV (66). Steroid 
hormones may cause thinning of the vaginal mucosa thereby aiding viral entry; may increase 
target cells or may alter immune mechanisms at the mucosal level (66). A study of HIV-1 
serodiscordant couples enrolled in HIV-1 incidence studies in seven African countries found 
an association with HIV risk (HR 1.98, 95% CI 1.06-3.68; p=0.03) among users of hormonal 
contraception versus non-users (67). In the same study hormonal contraception use 
significantly increased transmission risk to male partners (HR 1.97, 95% CI 1.12-3.45; 
p=0.02) (67). Contrary to this, a secondary analysis from the Carraguard study conducted in 
South Africa did not find an association between hormonal contraception use and HIV risk 
(68). A recent systematic review which included eight observational studies found no 




3.2.2.4. Sexually Transmitted Infections  
Sexually transmitted infections are known to increase susceptibility to HIV and facilitate 
transmission of HIV by increased viral shedding (70). Ulcerative and non-ulcerative STIs 
interact synergistically with HIV. Genital ulceration may lead to increased target cells in 
genital tract thereby aiding HIV entry or HIV may enter directly via ruptured blood vessels in 
ulcerative lesions (71). Among women in Uganda and Zimbabwe, HSV type 2, the 
commonest ulcerative STI, increased risk for HIV by two to four-fold in women with 
seroprevalent HSV type 2 infection and by four to eight-fold in women with  seroincident 
HSV type 2 infection (72). Non-ulcerative STIs are also known to increase susceptibility to 
HIV by causing inflammation of the genital tract thereby increasing HIV target cells (73). 
Genital tract infections caused by Trichomonas vaginalis, Neisseria gonorrhoeae and 
Chlamydia trachomatis, prevalent in South Africa, may increase HIV acquisition from 
anywhere between two and five-fold (71, 74). Among women in Durban, South Africa, 
Neisseria gonorrhoeae was found to increase HIV risk by more than four-fold (HR 4.62, 95% 
CI 1.34-15.93; p=0.015) (73). A high level of genital inflammation was evident in women 
with both symptomatic and asymptomatic STIs (73). Non-STI genital infections such as 
bacterial vaginosis (RR 1.6, 95% CI 1.2-2.1) have been associated with increased risk for 
HIV acquisition (75). Despite the well-known association between STIs and HIV, only one 
randomised controlled trial from Mwanza, Tanzania, has shown a significant reduction in 
HIV acquisition following the use of STI enhanced management as an intervention at a 
community level (76). However, conflicting results emerged from similar trials conducted in 
Rakai and Masaka in Uganda (77, 78). Differences in the stage of the HIV epidemic, sexual 
behaviour, curable STI rates, treatment for symptomatic versus asymptomatic STIs and 
enhanced STI services versus intermittent mass treatment across these regions are some of 
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the reasons cited for the contrasting findings of these trials (79, 80). Nevertheless, enhancing 
treatment of STIs is an important public health measure. 
 3.2.3. Host Genetics 
There are several genes which have been identified that are associated with HIV risk. The 
most commonly known genetic mutation is the 32-base pair deletion in the gene which codes 
for the human chemokine receptor 5 (CCR5), confined to Caucasians of Northern European 
descent (81). This cell receptor is used by the virus to gain entry into CD4+ cells. Genetic 
mutations lead to a person having no CCR5 receptors or greatly reduced number of receptors 
however neither confers total protection against HIV as a person may still be susceptible to 
C-X-C chemokine receptor type 4 (CXCR4) strains (81).  
Human leukocyte antigen (HLA) classes I and II are also implicated in HIV susceptibility and 
resistance. Commonly, HLA-B57 phenotype is associated with restriction of viral replication 
and non-progression of disease (82). Contrary to this, other HLA types such as HLA-B35 
have demonstrated quicker progression to AIDS in a study among homosexual men (83). 
Other studies of host genetics and HIV have found that greater expression of human TRIM5α 
(TRIM5αhu) coded for by the TRIM5αhu gene, is associated with reduced susceptibility to 
HIV among high risk women (84). Increased production of Interleukin-10, an anti-
inflammatory cytokine coded for by the IL-10 gene, has been shown to reduce HIV 
susceptibility in the same cohort (85). Another study using data from this cohort of women 
found that women with higher white blood cell counts, specifically the neutrophil subset, had 
a reduced risk of HIV infection while higher platelet counts increased risk for HIV infection 
(86). This finding was found to be linked to Duffy-null-associated low neutrophil count trait, 
common in African populations (86).  
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3.2.4. Immune Status 
In HIV-1 infection, CD4+ cells which are the helper T lymphocytes are the major targets for 
HIV infection and are able to replicate high levels of virus (87). Once infection is established, 
T-cells expressing CD4+ cell decline leading to lowered immunity. CD4+ cell counts are used 
clinically to determine when ART should be initiated. T-cell immunity appears to differ 
among races with HIV negative Caucasians having higher CD4+ cell counts compared to 
Asians and some African populations (88). Among the African population one study found 
that CD4+ cell loss following HIV acquisition is slow and  more noticeable at higher CD4+ 
cell counts (88). After ART initiation the CD4+ cell recovery does not appear to differ 
between races (88). Another study found that among injection drug users low pre-
seroconversion CD4+ cell counts were associated with a faster rate in CD4+ cell decline post 
infection (89). No studies were identified which evaluated pre-seroconversion CD4+ cell 
counts and risk for HIV acquisition. 
3.2.5. Nutritional status 
Several studies have explored nutritional status and HIV risk. In Pune, India, patients with 
STIs and low B-carotene levels were 21 times more likely to become infected with HIV (OR 
21.1, 95% CI 1.95-228.9) (90). A study in North America found differences in mean 
globulin, serum sodium, albumin and haemoglobin levels in HIV positive and HIV negative 
patients older than 55 years (91). A serum albumin to globulin ratio <1 predicted HIV 
seropositivity in patients with a background history of alcohol use or STI (91). In Rwanda, 
nutritional status did not differ between women who seroconverted and those who remained 
HIV negative (92). Pre-seroconversion levels of vitamin A, carotenoids, vitamin E, selenium, 
albumin, ferritin and cholesterol did not differ between the two groups (92). Among Kenyan 
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men with concomitant STIs, vitamin A deficiency, although common, was not associated 
with increased risk of HIV acquisition (93). 
Thus it is important to understand biological factors and whether these contribute individually 
or interact to either protect against or enhance HIV acquisition. 
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3.3. Behavioural Factors Which Contribute to HIV Risk 
Behavioural risk factors at the individual level which may determine risk for HIV acquisition 
include sexual risk behaviour such as early sexual debut, age disparate relationships, 
transactional sex, number of sex partners and partner concurrency, condom and alcohol or 
substance use (15, 18). Vaginal insertion practices performed either for hygiene purposes or 
for sexual motivation may also place women at increased risk for HIV (94, 95).  
 
3.3.1. Sexual Risk Behaviour 
3.3.1.1. Early Sexual Debut 
Given the high background prevalence of HIV in Southern Africa, early sexual debut in this 
setting immediately places individuals at risk of HIV. In Johannesburg, South Africa, sexual 
debut before 16 years of age was found to be an independent risk factor for HIV among 
women enrolled in an HIV prevention trial (OR 2.60, 95% CI 1.30-5.17, p=0.01) (96). A 
national survey found that among young men and women early sexual debut was more likely 
if the first sexual partner was older and among women who reported forced sex (97). In 
KwaZulu-Natal province, sexual debut at age 15 years or younger was associated with the 
highest HIV incidence (IR 12.0 per 100 person years, 95% CI 8.0-18.0) however women in 
this study were also more likely to engage in other risky sexual behaviours (98). 
3.3.1.2. Age Disparate Relationships  
In Southern Africa, women aged below 20 years are almost six times more likely to be HIV 
infected than their male counterparts (10). While sexual activity may not necessarily be 
higher among young women, it is the sexual partnering of  young women with older men that 
is thought to contribute to increased risk for HIV in this setting (10). Older men are more 
likely to be HIV infected than young men, thereby placing young women at increased risk for 
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HIV. A review of 56 studies in SSA found that among women having a sexual partner who is 
10 or more years older, the relative risk of HIV was double in women aged 15 to 19 years 
compared to 20 to 24-year-olds (99). Similarly, the national youth survey in South Africa 
found that among 15 to 19-year-olds, risk for HIV was increased if the partner was five or 
more years older (aOR 3.20, 95% CI 1.20–8.30) and among 20 to 24-year-olds risk was 
increased if the partner was between one and four years older (aOR 2.30, 95% CI 1.40-3.60) 
when compared to women having partners the same age or younger (100). In contrast, 
findings from a population based study of 15 to 29-year-old women in rural Hlabisa, 
KwaZulu-Natal found no association between partner age disparity and HIV risk, even when 
the analysis was restricted to 15-19 year old women (101). Limitations cited for this study 
include attrition of the cohort over time, non-response and misreporting of partners age. 
Furthermore, economic disparities may be less common in this rural setting as compared to 
urban areas of South Africa, thereby minimising risk of engaging in relationships with high 
risk older men (101). 
3.3.1.3. Transactional Sex and Commercial Sex Work  
Closely linked to age disparate relationships is transactional sex which is the exchange of sex 
for money or goods which is not implicitly considered to be commercial sex work. Young 
women are thought to engage in relationships with older men for financial gain among other 
reasons (15, 102). In a systematic review of 68 epidemiological studies conducted in Africa, a 
history of transactional sex was more frequent among HIV infected women compared to HIV 
uninfected controls (OR 2.29, 95% CI 1.45-3.62) (103). In Western Cape province, South 
Africa, 26.7% of women who engaged in casual sexual relationships disclosed a history of 
transactional sex (104). Among antenatal clinic attendees in Soweto, South Africa, 21% of 
women reported ever engaging in transactional sex and this was more common in women 
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who had a history of partner violence, substance use, poor living conditions and urban 
residence (105). In the same study, transactional sex was found to increase risk for HIV 
acquisition (OR 1.54, 95% CI 1.07-2.21) (105).  
Commercial sex work, which is defined as the exchange of money for sexual services, is 
estimated to range from <1% to around 4% of the female adult population in major cities and 
other urban areas in SSA (106). Unemployment or low socio-economic status, poverty, food 
insecurity, having a number of dependents or a low educational level and drug and alcohol 
dependence are some of the reasons women enter sex work (106). It is associated with a high 
burden of HIV with prevalence among sex workers and their clients estimated to be 10-20 
times higher than the general population in SSA (106). There is a paucity of HIV prevalence 
data in South Africa with the estimate from 1998 being between 50 to 70% among female 
commercial sex workers  (106). Sex workers are also burdened by high rates STIs including 
gonorrhoea which has been associated with increased HIV risk among older female sex 
workers in Johannesburg (107). Among female sex workers in Durban, engaging in anal sex 
was found to increase HIV risk by two-fold (52). In a separate study undertaken in Durban, 
evaluating coping mechanisms with the threat of HIV, HIV awareness was high, however this 
did not translate into safer sex practices (108).Vaginal insertion practices are a common 
occurrence among sex workers and may further predispose women to HIV (95). Alcohol and 
drug use before sex acts is known to reduce the likelihood of condom use in this group (95). 
While the number of sex clients vary across regions, emphasis on safer sex practices rather 
than reducing demand for commercial sex is the cornerstone of most sex worker care 
programmes (106). For these reasons female sex works remain at high risk group within 
South Africa and efforts to limit HIV incidence in this group is important to curb HIV in the 
context of the larger generalised epidemic. 
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3.3.1.4. Number of Sex Partners Including Multiple Concurrent Partnerships 
Several studies have demonstrated that HIV risk increases with an increasing number of 
sexual partners (31, 34, 103). While multiple concurrent partnerships is thought to be a key 
driver of the epidemic in Southern Africa, the number of sequential lifetime partners also 
appears to increase risk for HIV (109). A systematic review of 68 studies conducted in Africa 
found that the odds of HIV infection in women reporting three or more lifetime sex partners 
was almost four times higher than in those reporting between zero and two partners (OR 3.64, 
95% CI 2.87-4.62) (103). In Cameroon, HIV prevalence was higher among women reporting 
two or more sex partners in the last 12 months or four or more lifetime sex partners (34). In 
Johannesburg, South Africa, the risk of HIV infection was five-fold higher in women 
reporting two or more lifetime partners (OR 4.88, 95% CI 3.01-7.89; p=0.001) while women 
in KwaZulu-Natal reporting multiple sexual partners were at increased risk for HIV [adjusted 
odds ratio (aOR) 1.78, 95% CI 1.11-2.85; p=0.02] (31, 96). In a national survey among 15 to 
24-year-old youth, having multiple concurrent partners (OR 3.40, 95% CI 1.80-6.50; 
p<0.001) placed women at increased risk of HIV infection although concurrent partnerships 
and serial monogamy were equally common in women (110). Transactional sex and an 
inability to negotiate condom use was more often reported in these women (110). 
3.3.1.5. Condom Use 
Male or female condoms are a safe and effective method of preventing HIV infection. A 
review of 14 observational studies of HIV discordant couples found an 80% reduction in HIV 
incidence in people who always used condoms versus those that never used condoms (HIV 
incidence 1.14 per 100 person years, 95% CI 0.56-2.04 and 5.75 per 100 person years, 95% 
CI 3.16-9.66 respectively) (111). In South Africa, overall condom use at last sex act among 
males and females was found to be 36.2% (95% CI 34.5-37.9%) in the 2012 HSRC survey  
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(18). Condom use was reported more frequently among males, youth and Black Africans and 
was higher than the national average for most high risk groups including young Black 
African females (18). In another study of high-risk women, those who achieved a higher level 
of education or who used condoms as a contraceptive method were more likely to use 
condoms (112). Inconsistent condom use especially with long-term or stable partners and the 
inability of women to negotiate condom use remain some of the drawbacks of this prevention 
method.  
3.3.1.6. Alcohol and Substance Use 
The use of alcohol and other substances has been linked to HIV risk in several studies (113-
115). A systematic review of 21 studies conducted in SSA found that users of alcohol were 
more likely to be HIV positive than non-users, and the use of alcohol in relation to sex acts 
increased risk for HIV (114). A review of studies in Southern Africa confirmed these findings 
(113). The quantity of alcohol consumed rather than the frequency of alcohol intake was 
linked to risky sexual behaviour such as infrequent condom use, increased number of sex 
partners and partner concurrency (113). Similarly, the use of other substances eg. cannabis, 
cocaine, heroin and methamphetamines within and outside of the sexual context has been 
linked to increased HIV risk (115). A study which included non-injecting drug users in three 
major cities in South Africa found that substance use in relation to sexual activity led to 
sexual disinhibition and risky sexual behaviour such as anal sex and sex with multiple 
partners at the same time (116).  
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3.3.2. Vaginal Practices 
The use of substances in the vagina may potentially change the genital micro-environment 
thereby compromising host defences in the genital tract or may lead to epithelial disruption 
(94). Douching or ‘dry sex’ has been implicated as a risk factor for HIV acquisition (95). 
Vaginal practices differ between regions and are categorised, but are not limited to the 
following: external washing, external application of substances, intravaginal cleansing, 
intravaginal insertion and oral ingestion (94). Vaginal practices are common practice among 
both female sex workers and women not engaging in sex work in Africa (117, 118). Among 
867 women interviewed in women in KwaZulu-Natal, 90.2% of women engaged in vaginal 
practices which were undertaken for hygiene purposes or for sexual motivation, with 
intravaginal cleansing being the commonest vaginal practice (119, 120). The type of 
substances used to cleanse the vagina appears to influence HIV risk, with more abrasive 
substances likely to alter the vaginal flora to a greater extent. A ten year study of Kenyan sex 
workers found that women who practiced vaginal cleansing were at increased risk for HIV 
compared to those that did not (121). Risk for HIV was four-fold higher with intravaginal 
washing with soap (HR 3.84, 95% CI 1.51-9.77; p=0.005) and three-fold higher in those who 
washed with water only (HR 2.64, 95% CI 1.00-6.97; p=0.05) compared to women who did 
not practice vaginal washing, after adjusting for demographic variables, sexual behaviour and 
STIs (121). Among Zimbabwean and Ugandan women, vaginal cleansing was not associated 
with HIV acquisition (122). In South Africa, no association was found between vaginal 
practices and incident HIV infection (123). Vaginal practices were associated with injectable 
hormonal contraception use and bacterial vaginosis in two separate studies indicating that 
other risk factors for HIV need to be excluded when exploring the association between 
vaginal practices and HIV risk (119, 124). 
28 
 
While behavioural risk factors contribute substantially to the HIV burden, these factors must 
be interpreted in the context of the broader structural factors in this setting which may 
influence risk behaviour. Nevertheless, understanding the role of these factors to modify 




3.4. Knowledge of HIV 
An adequate knowledge of HIV prevention and transmission is key for willingness to engage 
HIV prevention modalities. Studies undertaken in SSA show variation in trends of HIV 
knowledge (125-128). A review of health surveillance data from 16 countries in SSA, found  
that knowledge of blood-borne transmission of HIV was inversely correlated to HIV 
prevalence at a national level (128). In rural Nigeria knowledge about HIV transmission was 
generally high among 210 adults interviewed with the majority of participants having a good 
or fair knowledge of HIV (125). A survey of health care workers including physicians, 
midwives, nurses, medical students and nursing auxiliaries in Madagascar found that 
knowledge of transmission of HIV was poor and misconceptions were common (126). 
Among young urban women in Kenya, comprehensive HIV knowledge had increased from 
9% in 1993 to 54% in 2008 and 2009 (127). The 2012 HSRC survey in South Africa found 
that 26.8% of the population had adequate knowledge about HIV sexual transmission and 
prevention. Knowledge levels differed by age, race, locality and province (18). Furthermore, 
between the 2008 and 2012 reporting periods knowledge of HIV decreased among all high 
risk groups with the exception of Black African females in whom knowledge of HIV 
increased marginally (18). Earlier studies of female sex workers in Limpopo province, South 
Africa, found that knowledge of HIV prevention was inadequate and some misconceptions 
regarding HIV transmission prevailed while in KwaZulu-Natal province knowledge of HIV 





This literature review emphasises the sustained high burden of HIV infection in women in 
South Africa and that while risk for HIV is multifactorial, it is incompletely elucidated in this 
setting. High risk behaviours such as having multiple sex partners, engaging in age–disparate 
relationships, using alcohol in relation to sex acts and being a sex worker may contribute 
significantly to HIV risk however biological factors such as STIs are also recognised as 
increasing HIV susceptibility in women (73, 96, 100, 106, 113). Consistent condom use is 
known to reduce risk for HIV and marriage also appears to attenuate risk, albeit in older age 
groups (18, 111). Ongoing research to further explore factors which increase susceptibility to 
HIV infection in women, particularly at the level of the female genital tract, may inform the 
development of biomedical interventions for women in future. Understanding risk for HIV in 
this setting is imperative to guide current prevention policy with regard to communicating the 
right messages and identifying and targeting groups at greatest risk of HIV. The role of 
structural factors and HIV risk must not be underestimated in this setting. In the long-term, 
structural approaches must be incorporated into current HIV policy if behavioural and 
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Risk factors for HIV acquisition in high risk women in a generalised epidemic setting 
 
Abstract 
In South Africa young women bear a disproportionate burden of HIV infection however, risk 
factors for HIV acquisition are not fully understood in this setting. In a cohort of 245 HIV 
negative women, we used proportional hazard regression analysis to examine the association 
of demographic, clinical and behavioural characteristics with HIV acquisition. The overall 
HIV incidence rate (IR) was 7.20 per 100 women years (wy), 95% Confidence Interval (CI) 
4.20–9.80]. Women 18 to 24 years had the highest HIV incidence [IR 13.20 per 100 wy, 95% 
CI 6.59–23.62] and were almost three times more likely to acquire HIV compared to women 
25 years and older [adjusted Hazard Ratio (aHR) 2.61, 95% CI 1.05–6.47]. Similarly, women 
in relationships with multiple sex partners [IR 8.97 per 100 wy, 95% CI 5.40–14.0] had more 
than twice the risk of acquiring HIV when compared to women who had no partner or who 
had a husband or stable partner (aHR 2.47, 95% CI 0.98–6.26). HIV prevention programmes 
must address young women’s vulnerability and promote safer sex practices for high risk 
women.  
 







Into the fourth decade of the Human Immunodeficiency Virus (HIV) epidemic, South 
Africa has an estimated 6.1 million people living with HIV and contributes 17% of the global 
HIV burden, yet accounts for only 0.7% of the world’s population (1, 2). With the majority of 
infections heterosexually acquired, young women bear a disproportionate burden of HIV. 
Sentinel surveillance among pregnant women shows that in 1990, HIV prevalence was 0.7% 
and by 1998 increased exponentially to 22.8%, peaking at 30.2% in 2010 (3). Data from 
national population based surveys show similar trends with high HIV prevalence in young 
women compared to young men (4, 5). HIV prevalence peaked at 36.0% among women aged 
30 to 34 years and at 28.8% among men in the 35 to 39 year–old age group (5). HIV 
prevalence in women aged 15 to 19 years was 5.6%, eight times higher than males in the 
same age group, and increased to 17.4% among women aged 20 to 24 years and 28.4% in the 
25 to 29 year age group (5). Within South Africa there is significant geographical variation in 
the distribution of HIV and the province of KwaZulu–Natal remains the worst affected (3, 6). 
Whilst HIV prevalence is an important tool to establish the burden of existing infections and 
to ascertain survival rates over time, HIV incidence rate is a more sensitive measure to 
monitor the epidemic as it indicates the rates of new infections as well as ongoing HIV 
transmission. Amongst rural and urban women in KwaZulu-Natal, the HIV incidence rates 
have been 6.5 and 6.4 per 100 women years (wy) respectively, and in young women younger 
than 18 years, 4.7 per 100 wy (7, 8). These data underscore the need to understand the risk 
factors contributing to these high HIV prevalence and incidence rates.  
The key risk factors for HIV in this setting include a combination of structural, 
behavioural and biological factors. Poverty, labour migration, urbanisation, gender 
inequalities and gender–based violence contribute to an increased susceptibility to HIV (6, 9). 
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At the individual level, being single, unemployed or not achieving a high school education 
increase vulnerability and predispose young women to HIV (5, 10, 11). High risk sexual 
behaviour such as engaging in multiple concurrent partnerships, transactional sex and age–
disparate relationships, has contributed significantly to enhancing HIV risk and is 
exacerbated by the inability of women to negotiate condom use even in long–term 
partnerships (9, 12-15). Physiological changes of the genital tract as well as factors which 
affect the integrity of the genital tract epithelium such as sexually transmitted infections 
(STIs) and intra–vaginal insertion practices, either for cleansing or enhancing sex, may 
increase susceptibility to HIV by facilitating HIV viral entry (9, 16-19). Recent data suggests 
that genital tract inflammation in women with symptomatic and asymptomatic STIs may 
upregulate HIV susceptible target cells at the mucosal level thereby aiding transmission (20). 
The association between hormonal contraception use, in particular progestogen–only 
injectable preparations, and HIV risk remains contentious as current biological and 
epidemiological evidence is limited (21, 22). 
As the HIV epidemic evolves, it is important to understand the factors that contribute 
to vulnerability and risk so that the design of HIV prevention programmes are tailored taking 
these into account. In this prospective cohort study we explored factors associated with HIV 
acquisition in a generalised epidemic setting.  
 
Methods 
Study Setting and Study Population  
This study is a secondary analysis of data collected in the Centre for the AIDS 
Programme of Research in South Africa (CAPRISA) 002 study. The CAPRISA 002 study 
was initiated to advance the understanding of HIV–1 subtype C acquisition, pathogenesis and 
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disease progression. Between August 2004 and May 2005 volunteers from the city of 
Durban, KwaZulu–Natal, South Africa were recruited for study participation. Eligibility 
criteria and screening and enrolment procedures have been described (23). Briefly women 18 
years and older, self–identifying as sex workers or having had at least three partners in the 
three months prior to recruitment, and testing HIV negative were eligible for study 
participation.  Although all women residing in KwaZulu-Natal province are known to be at 
high risk of HIV infection, the aim of the CAPRISA 002 study was to recruit women at 
greatest risk of HIV infection (23). Women were recruited from known sex worker sites in 
Durban (23). One of the challenges encountered in the development of this cohort is that the 
term sex worker or client was not always culturally appropriate when recruiting women (23). 
Using broader terms such as having ‘multiple partners who provide material needs in 
exchange for sex’ was used therefore used as a recruitment strategy (23).  
   
Study procedures  
Volunteers were provided with verbal and written information about the study 
objectives and procedures after which written consent for screening procedures and for long– 
term storage of specimens were obtained. Women agreeing to participate in the study 
received pre and post–test counselling for HIV testing and risk reduction counselling and had 
blood samples collected for HIV antibody testing. Women testing HIV positive were referred 
to support services for ongoing care and psychosocial support. All women testing HIV 
antibody negative or indeterminate were enrolled until the study endpoint of HIV infection or 
for a period of 24 months. 
At baseline, trained nurses administered questionnaires to all participants to obtain 
information regarding socio–demographic history, risk behaviour, knowledge about HIV and 
more direct questions related to sex work. A complete physical examination was undertaken 
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at baseline and at each monthly follow up visit. Urine pregnancy testing was done if clinically 
indicated or upon request by a participant (23). Pelvic examination for genital sample 
collection was undertaken at baseline and at six monthly intervals. Blood specimen collection 
was done at baseline (safety monitoring tests, serological testing for STIs and long–term 
storage), at each monthly visit (HIV testing) and at each six–monthly visit (safety monitoring 
tests and serological testing for STIs).  
Laboratory Evaluations 
HIV testing was done using two rapid antibody tests using the Determine HIV–1 test 
(Abbott Diagnostics, Johannesburg, South Africa) and the Capillus HIV–1/HIV–2 test 
(Trinity Biotech, USA) followed by HIV–1 RNA polymerase chain reaction (PCR) testing 
using the Cobas AmpliScreen Multiprep HIV–1 test version 1.5 and the Cobas 
AmpliPrep/Cobas Amplicor HIV–1 Monitor test version 1.5 (Roche Diagnostics, 
Branchburg, New Jersey, USA) if at least one rapid antibody test was negative (24). 
Confirmatory HIV ELISA testing was done on PCR positive samples (Enzynost anti HIV1/2 
plus Dade Behring, Deerfield, Illinois, USA) (24). HIV infection as endpoint was based on a 
positive HIV–1 antibody test with a previously documented negative HIV–1 antibody test; or 




Figure 1. HIV testing algorithm. ELISA, Enzyme-linked immunosorbent assay; PCR, 
polymerase chain reaction (24). 
 
Safety monitoring tests comprised haematological and biochemical evaluations. 
Genital specimens were tested for Neisseria gonorrhoeae, Chlamydia trachomatis, 
Trichomonas vaginalis, Mycoplasma genitalium and herpes simplex virus (HSV) type 2 using 
PCR and bacterial vaginosis (BV) was diagnosed on Gram–stained smears using Nugent’s 
criteria. Syphilis [Becton Dickinson Macro–Vue RPR (rapid plasma reagin) card test and 
Omega ImmuTrep TPHA test], HSV infection (HerpeSelect–1 and HerpeSelect–2) and 
hepatitis B (HBV) infection (CENTAUR XP) were diagnosed serologically.  
Data Management 
Demographic, behavioural, clinical and laboratory data were captured onto 
standardised case report forms (CRFs) which were coded with a participant identification 
number in order to maintain participant confidentiality. CRFs were faxed using the DataFax 
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system (Clinical DataFax Sytems Inc., Ontario, Canada), with all data verified by data 
encoders for quality checks and stored in a secure study specific database. 
Measures 
HIV–1 infection was the main outcome measure. Baseline information on socio– 
demographic factors (age, number of dependents, educational level), behavioural factors (age 
at sexual debut, relationship status, frequency and type of sex acts, male and or female 
condom use [defined as condom use at last sex act], contraception type, douching, alcohol 
and substance use during sex), sex for compensation (time period involved in sex work, age 
started sex work, days per week engaged in sex work, number of sites worked at, number of 
sex clients, short sessions or overnight stays per week with clients and condom use), clinical 
factors, including pregnancy and laboratory measures (full blood counts, liver function tests, 
electrolytes, vitamin B12, folate, iron, glucose, calcium, phosphate, CD4+, CD3+ and CD8+ 
cell counts and STIs), and knowledge questions on HIV prevention and transmission were 
obtained.  
Statistical Analysis  
This was an observational cohort at high risk of acquiring HIV, designed to answer 
questions regarding HIV pathogenesis during acute HIV infection. Thus for the purposes of 
this analysis, the cohort was analysed as an observational cohort, including all HIV negative 
women in the original design, and therefore no sample size calculation was performed. 
Baseline data were summarised using descriptive statistics, with continuous variables 
reported as means and standard deviations or medians and interquartile ranges, while 
categorical variables are reported as percentages and actual numbers. Unadjusted and 
adjusted proportional hazards regression analysis was performed to assess the impact of 
socio–demographic factors, risk behaviour, sex for compensation and clinical factors on HIV 
acquisition. Estimated time of HIV infection was defined as the midpoint between the last 
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negative HIV ELISA and the first positive HIV ELISA or 14 days prior to a positive HIV–1 
RNA test if the HIV ELISA is negative on the same day (23). Time to HIV infection was 
calculated from the date of enrolment until the estimated time of HIV infection. HIV 
incidence rate was calculated as [Incidence Rate (IR) = number of HIV cases / total person 
years at risk X 100] and confidence intervals (CI) for IR assumed a Poisson distribution. 
Participants who remained HIV negative were censored at their last visit. Factors with a p–
value of less than 0.2 in the unadjusted analysis were included in the adjusted model. As anal 
sex is known to be a risk factor for HIV acquisition, even among high risk women, this 
variable was included in a multivariable model (25, 26). Although current evidence for 
contraception and HIV risk is limited, this variable was also included given the biological 
plausibility of this variable with HIV risk (9, 27, 28). The first multivariable model included 
all women, sex workers and women reporting more than three sexual partners (Table 2). In 
this model some variables relating to sex work had a p–value of less than 0.2 in the 
unadjusted analysis, however these were not included in the adjusted model, because a large 
proportion of the cohort did not identify themselves as sex workers. The second multivariable 
model (Table 2) was restricted to women reporting sex for compensation. All variables 
related to sex work with a p-value of less than 0.2 in the unadjusted model were included in 
the final adjusted model.  
P–values less than 0.05 were considered statistically significant. Analysis was 
performed using SAS software version 9.3 (SAS Institute Inc., Cary).  
Ethics Approval 
Ethics approval for the CAPRISA 002 study was obtained from the Universities of 
Natal (E013/04), Cape Town (025/2004) and Witwatersrand (MM040202). The ethical 
approval for the secondary analysis of data was granted from the Biomedical Research Ethics 
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Committee, University of KwaZulu–Natal (BE 092/11) and permission to review data stored 
in the CAPRISA 002 database was approved through the CAPRISA data sharing policy.   
 
Results 
A total of 775 women were screened of whom 509 (65.7%) were ineligible for  the 
following reasons: tested HIV positive  (n=462; 59.6%), reported less than three sexual 
partners in the previous three months (n=22; 2.8%), were pregnant (n=16; 2.1%), planned to 
relocate (n=4; 0.5%), younger than 18 years (n=3; 0.4%) or afraid of testing procedures (n=2; 
0.3%) (23). Twenty–one (2.7%) women were eligible for study participation but did not 




Figure 2. CAPRISA 002 Screening and Enrolment  
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After 390 wy of follow up, 28 women acquired HIV, yielding an incidence rate (IR) 
of 7.20 per 100 wy [95% CI 4.20–9.80]. Women aged 18 to 24 years had the highest HIV 
incidence (IR 13.20 per 100 wy, 95% CI 6.59–23.62). The HIV incidence among women 25 
years and older was 4.58 per 100 wy (95% CI 2.50–7.68). Three women were excluded from 
any risk factor analyses as they were in the window period of HIV infection at study entry.   
The baseline characteristics overall and of those acquiring HIV are shown in Table I.  
The mean age of 242 women was 34.3 years [standard deviation (SD) 10.47, range 18–58], 
185 (76.8%) women had one or more dependents and 156 women (64.5%) had an educational 
level which was above grade 8. The mean age at sexual debut was 17 (SD 2.38, range 12–26) 
years. Although a large proportion (191; 78.9%) self–identified themselves as sex workers, 
having spent a median of three years [interquartile range (IQR) 1.3–8.3] in sex work, only 
137 (56.6%) women reported being in a relationship with multiple partners at the time of the 
study.   
Women who acquired HIV were approximately five years younger than those who 
remained HIV negative [t statistic (t)=2.20, p=0.029], reported being in relationships with 
multiple partners more frequently [Fisher’s exact test hypergeometric probability 
(Fprob)=0.02, p=0.054] and had higher baseline serum vitamin B12 levels (t=-2.00, 
p=0.047). 
Table II shows the socio–demographic, behavioural and biological variables 
associated with risk of HIV acquisition overall and by sex work. Younger women, aged 18 to 
24 years were almost three times more likely to acquire HIV compared to women 25 years 
and older [Hazard Ratio (HR) 2.85, 95% CI 1.29–6.28; Chi-square test statistic (χ2)=6.73; 
p=0.010] and similarly women reporting many partners were also at almost three times 
greater risk of HIV acquisition (HR 2.61, 95% CI 1.04–6.52; χ2=4.18; p=0.041). A higher 
educational level, above grade 8, was weakly associated with increased risk for HIV (HR 
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2.45, 95% CI 0.92–6.52; χ2=3.21; p=0.073) as were STIs (HR 2.47, 95% CI 0.93 – 6.58; 
χ2=3.26; p=0.071), but no significant associations were found for HIV risk and engaging in 
anal sex (HR 1.49, 95% CI 0.68–3.29; χ2=0.99; p=0.321) or delayed sexual debut (HR 0.88, 
95% CI 0.73–1.06; χ2=1.88; p=0.170).   
Among women reporting sex for compensation, HIV risk remained three–fold higher 
among 18 to 24 year–old women (HR 3.27, 95% CI 1.29–8.30; χ2=6.24; p=0.013) and ten–
fold higher among those reporting many partners (HR 10.32, 95% CI 1.37–77.55; χ2=5.15; 
p=0.023). Weak associations were found between increased HIV risk and every additional 
overnight stay per week with clients (HR 1.33, 95% CI 0.94–1.88; χ2=2.61; p=0.106) and 
reduced risk for every additional year spent in sex work (HR 0.93, 95% CI 0.85–1.02; 
χ2=2.34; p=0.126).  
In the final multivariable model overall, young age remained significant for HIV risk 
(HR 2.61, 95% CI 1.05–6.47; χ2=4.27; p=0.039) and by sex work, having multiple partners 




Table I: Baseline socio–demographic, behavioural and biological characteristics of women, overall and by HIV statusa, Durban, South Africa, 2004/2007 
Variable Total  
(n = 242) 
HIV Positive  
(n = 25) 
HIV Negative  
(n = 217) 





Age in years (Mean, ±SD) 34.3 (10.47) 30.0 (10.37) 34.8 (10.39) t=2.20 0.029 
Age group (in years) % (n)      
18– 24 26.54% (64) 44.0% (11) 24.4% (53) Fprob=0.0230 0.053 
≥ 25 73.6% (178) 56.0% (14) 75.6% (164)   
Number of dependents % (n) 
0 23.2% (56) 16.0% (4) 24.1% (52) Fprob=0.1429 0.460 
≥ 1 76.8% (185) 84% (21) 75.9% (164)   
Educational level % (n) 
≤Grade 8 35.5% (86) 20.0% (5) 37.3% (81) Fprob=0.0416 0.121 
> Grade 8 64.5% (156) 80.0% (20) 62.7% (136)   
Risk behaviour 
Age in years at sexual debut (Mean, ±SD) 17.0 (2.38) 16.5 (1.76) 17.1 (2.44) t=1.18 0.239 
Relationship status % (n) 
No partner or Stable/Married partner 43.2% (104) 24.0% (6) 45.4% (98) Fprob=0.0212 0.054 
Many partners 56.6% (137) 76.0% (19) 54.4% (118)   
Mean sex acts per month (±SD) 10.3 (6.78) 10.3 (5.03) 10.3 (6.97) t=-0.01 0.994 
Type of sex act % (n) 
Ever had vaginal sex 100% (242) 100% (25) 100% (217) – –  
Ever had anal sex 34.6% (83) 44.0% (11) 33.5% (72) Fprob=0.0997 0.374 
Ever had oral sex 25.3% (61) 24.0% (6) 25.5% (55) Fprob=0.1915 1.000 
Condom use at last sex act % (n) 
Yes 58.7% (142) 64.0% (16) 58.1% (126) Fprob=0.1469 0.670 
No 41.3% (100) 36.0% (9) 41.9% (91)   
Any contraception % (n) 79.7% (192) 68.0% (17) 81.0% (175) Fprob=0.0635 0.185 
Contraception type % (n) 
Condom only 41.5% (100) 36.0% (9) 42.1% (91) Fprob=0.0296 0.808 
Hormonal 30.7% (74) 32.0% (8) 30.5 (66)   
None/Otherc 27.8% (67) 32.0% (8) 27.2% (59)   
Douching after sex % (n) 9.5% (23) 4.0% (1) 10.2% (22) Fprob=0.2096 0.483 
Sex after alcohol or substance use % (n) 
Yes 26.9% (65) 20.0% (5) 27.7% (60) Fprob=0.1441 0.484 
No 73.1% (177) 80.0% (20) 72.4% (157)   
Sex for compensation 
Self–reported sex workers % (n) 78.9% (191) 72.0% (18) 79.7% (173) Fprob=0.1287 0.436 
Years in sex work (Median, IQR) 3.0 (1.3 – 8.3) 2.5 (1.0 – 7.0) 3.0 (1.3 – 9.0) Z=-1.36 0.179 
Age at start of sex work (Mean, ±SD) 28.2 (9.02) 27.2 (10.16) 28.3 (8.92) t=0.49 0.625 
Days per week perform sex work (Mean, ±SD) 2.9 (1.40) 2.9 (1.55) 2.9 (1.39) t=-0.21 0.835 
Sites worked  per year (Mean, ±SD) 2.6 (1.30) 2.8 (0.86) 2.6 (1.33) t=-1.08 0.291 
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Table I: Baseline socio–demographic, behavioural and biological characteristics of women, overall and by HIV statusa, Durban, South Africa, 2004/2007 
Variable Total  
(n = 242) 
HIV Positive  
(n = 25) 
HIV Negative  
(n = 217) 




Clients per day (Mean, ±SD) 2.5 (1.19) 2.6 (1.24) 2.5 (1.19) t=-0.36 0.722 
Clients in the past week (Mean, ±SD) 3.1 (3.83) 2.4 (2.53) 3.1 (3.94) t=1.01 0.323 
Short sessions per week (Mean,  ±SD) 4.2 (4.05) 3.6 (4.68) 4.3 (3.99) t=0.63 0.527 
Overnight stays per week (Mean,  ±SD) 1.1 (1.20) 1.4 (1.34) 1.0 (1.19) t=-1.46 0.147 
Condom use in the last month % (n)      
Always 38.2% (73) 27.8% (5) 39.3% (68) Fprob=0.0332 0.650 
Sometimes 42.9% (82) 50.0% (9) 42.2% (73)   
Never 18.9% (36) 22.2% (4) 18.5% (32)   
HIV knowledge 
How safe is anal sex compared to peno–vaginal sex? % (n) 
Same or more risk 62.8% (152) 56.0% (14) 63.6% (138) Fprob=0.0021 0.278 
Less risk or don’t know 37.2% (90) 44.0% (11) 36.4% (79)   
How safe is oral sex compared to peno–vaginal sex? % (n) 
Same or more risk 71.8% (173) 68.0% (17) 72.2% (156) Fprob=0.1629 0.644 
Less risk or don’t know 28.2% (68) 32% (8) 27.8 (60)   
If you have an STI are you more likely to get HIV? % (n) 
Yes 71.1% (172) 80.0% (20) 70.1% (152) Fprob=0.0850 0.665 
No 1.7% (4) 0.0% (0) 1.8% (4)   
Only sometimes/unsure 27.3% (66) 20.0% (5) 28.1% (61)   
Do you think HIV can be treated? % (n) 
Yes  95.0% (230) 96.0% (24) 94.9% (206) Fprob=0.1587 0.516 
No 2.1% (5) 4.0% (1) 1.8% (4)   
Unsure 2.9% (7) 0.0% (0) 3.2% (7)   
Clinical evaluation      
Ever pregnant prior to HIV % (n) 
Yes 10.3% (25) 12.0% (3) 10.1% (22) Fprob=0.2441 0.730 
No 89.7% (217) 88.0% (22) 89.9% (195)   
Laboratory parameters 
Haemoglobin g/dL (Mean, ±SD) 12.7 (1.29) 12.8 (1.43) 12.7 (1.27) t=-0.51 0.613 
Eosinophils 1 x 109/L (Mean, ±SD) 0.2  (0.24) 0.3  (0.25) 0.2 (0.24) t=-0.81 0.420 
Albumin g/L(Mean, ±SD) 44.7 (3.57) 44.8 (3.32) 44.7 (3.60) t=-0.02 0.981 
Vitamin B12 pg/mL (Mean, ± SD) 291.0 (93.14) 327.6 (112.19) 287.0 (90.25) t=-2.00 0.047 
Folate ng/mL (Mean, ±SD) 22.4 (8.45) 20.8 (8.54) 22.6 (8.45) t=0.94 0.346 
Serum iron µmol/L (Mean, ±SD) 12.3 (6.41) 12.1 (5.36) 12.3 (6.53) t=0.16 0.877 
Random glucose mmol/L (Mean, ±SD) 5.2 (2.02) 4.7 (0.85) 5.3 (2.11) t=2.72 0.008 
Sodium mmol/L (Mean, ±SD) 137.1 (2.22) 138.2 (2.08) 137.0 (2.21) t=-2.66 0.008 
Potassium mmol/L (Mean, ± SD) 4.0 (0.32) 4.1 (0.41) 4.0 (0.32) t=-0.35 0.730 
Chloride mmol/L (Mean, ±SD) 103.0 (2.55) 103.9 (1.98) 102.9 (2.59) t=-1.93 0.054 
Calcium mmol/L (Mean, ±SD) 2.4  (0.12) 2.4 (0.09) 2.4 (0.12) t=-0.67 0.501 
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Table I: Baseline socio–demographic, behavioural and biological characteristics of women, overall and by HIV statusa, Durban, South Africa, 2004/2007 
Variable Total  
(n = 242) 
HIV Positive  
(n = 25) 
HIV Negative  
(n = 217) 




Phosphate mmol/L (Mean, ±SD) 1.1  (0.18) 1.1  (0.17) 1.0  (0.18) t=-1.43 0.155 
HIV negative CD4+ count cells/µl (Median, IQR) 888  (742 –  1132) 969 (855 –  1068) 878 (738 –  1132) Z=0.76 0.446 
HIV negative CD3+ count cells/µl (Median, IQR) 1493  (1202 –  1839) 1522 (1324– 1857) 1486 (1197– 1822) Z=0.58 0.564 
HIV negative CD8+ count cells/µl (Median,  IQR) 517 (402– 688) 500 (420– 760) 520 (402– 680) Z=-0.04 0.966 
Bacterial vaginosis % (n) 52.7% (127/241) 68.0% (17) 50.9% (110/216) Fprob=0.0465 0.139 
Sexually transmitted infectiond % (n) 31.3% (75/240) 44.0% (11) 29.8% (64/217) Fprob=0.0625 0.172 
a HIV status as at end of follow-up period 
bTest statistic are: t=t-tests or Z=Wilcoxon Rank Sums (Normal Approximation), for continuous variables; Fprob=Fisher’s exact test hypergeometric probability, for categorical 
data 
c Female sterilisation or rhythm/calendar method 
d Any STI present if participant tested positive for syphilis antibodies or Trichomonas vaginalis, Neisseria gonorrhoeae, Mycoplasma genitalium, Chlamydia trachomatis or 





Table II: Socio–demographic, behavioural and biological risk factors for HIV acquisition in women, overall and by sex work, Durban, South Africa, 2004/2007 




Cases/ PY  
at risk 
HIV Incidence  
(95% CI) 
Univariate 












HIV Incidence  
(95% CI) 
Univariate 









Demographic characteristics       
Age group (in years)  
≥25 14/305.90 4.58 (2.50 – 7.68) 1.00  –  1.00  –  10/248.35 4.03 (1.93 – 7.40) 1.00  –  1.00  –  
18–24  11/83.32 13.20 (6.59 – 23.62) 2.85 (1.29 – 6.28) 0.010 
(χ2=6.73) 
2.61 (1.05 – 6.47) 0.039 
(χ2=4.27) 
8/59.36 13.48 (5.82 – 26.56) 3.27 (1.29 – 8.30) 0.013 
(χ2=6.24) 
2.44 (0.79 – 7.56) 0.123 
(χ2=2.38) 
Number of dependents 
None  4/79.27 5.05 (1.37 – 12.92) 1.00  –    3/62.58 4.79 (0.99 – 14.01) 1.00  –    
1 or more  21/309.13 6.79 (4.21 – 10.38) 1.36 (0.47 – 3.95) 0.576 
(χ2=0.31) 
  15/244.31 6.14 (3.44 – 10.13) 1.29 (0.37 – 4.46) 0.686 
(χ2=0.16) 
  
Educational level       
Grade ≤8 5/148.20 3.37 (1.10 – 7.87) 1.00  –  1.00  –  4/115.79 3.45 (0.94 – 8.85) 1.00  –  1.00  –  
Grade >8 20/241.02 8.30 (5.07 – 12.82) 2.45 (0.92 – 6.52) 0.073 
(χ2=3.21) 
1.92 (0.65 – 5.68) 0.241 
(χ2=1.37) 
14/191.92 7.29 (3.99 – 12.24) 2.10 (0.69 – 6.39) 0.190 
(χ2=1.72) 
1.45 (0.40 – 5.20) 0.570 
(χ2=0.32) 
Behavioural characteristics       
Age at sexual debut (per 1 year increase)  0.88 (0.73 – 1.06) 0.170 
(χ2=1.88) 
0.86 (0.71 – 1.05) 0.149 
(χ2=2.08) 
  0.96 (0.78 – 1.19) 0.707 
(χ2=0.14) 
  
Relationship status       
No partner or 
stable/ married 
partner 
6/175.52 3.40 (0.09 – 18.92) 1.00 –  1.00 –  1/117.30 0.85 (0.02 – 4.75) 1.00 –  1.00 –  
Many Partners 19/211.75  8.97 (5.40 – 14.01) 2.61 (1.04 – 6.52) 0.041 
(χ2=4.18) 
2.47 (0.98 – 6.26) 0.056 
(χ2=3.65) 
17/190.41 8.93 (5.20 – 14.29) 10.32 (1.37 –77.55) 0.023 
(χ2=5.15) 
8.55 (1.11 – 6.02) 0.040 
(χ2=4.23) 
Average no. of sex acts per month (per 1 act increase) 1.00 (0.94 – 1.06) 0.954 
(χ2<0.01) 
    0.99 (0.93 – 1.06) 0.801 
(χ2=0.06) 
  
Ever had anal sex           
No 14/253.73 5.52 (3.02 – 9.26) 1.00  –  1.00  –  9/192.44 4.68 (2.14 – 8.88) 1.00  –  1.00  –  
Yes 11/133.33 8.25 (4.12 – 14.76) 1.49 (0.68 – 3.29) 0.321 
(χ2=0.99) 
1.65 (0.73 – 3.74) 0.230 
(χ2=1.44) 
9/115.11 7.82 (3.57 – 14.84) 1.66 (0.66 – 4.19) 0.281 
(χ2=1.16) 
1.68 (0.63 – 4.47) 0.301 
(χ2=1.07) 
Ever had oral sex       
No 19/293.53 6.47 (3.90 – 10.11) 1.00  –    13/225.89 5.76 (3.06 – 9.84) 1.00  –    
Yes 6/94.75 6.33 (2.32 – 13.78) 0.97 (0.39 – 2.44) 0.955 
(χ2<0.01) 
  5/80.88 6.18 (2.01 – 14.43) 1.07 (0.38 – 2.99) 0.902 
(χ2=0.02) 
  
Condom use at last sex act       
Yes 16/225.00 7.11 (4.06 – 11.55) 1.00  –    11/173.32 7.11 (6.35 – 11.36) 1.00  –    
No 9/164.22 5.48 (2.51 – 10.40) 0.77 (0.34 – 1.75) 0.534 
(χ2=0.39) 
  7/134.39 5.21 (2.09 – 10.73) 0.82 (0.32 – 2.12) 0.684 
(χ2=0.17) 
  
Contraception type       
Condom only 9/161.76 5.56 (2.54 – 10.56) 1.00  –  1.00  –  7/127.41 5.49 (2.21 – 11.32) 1.00  –  1.00  –  
Hormonal 8/118.78 6.75 (2.91 – 13.31) 1.21 (0.47 – 3.14)  0.692 
(χ2=0.16) 
1.03 (0.38 – 2.76) 0.958 
(χ2<0.01) 
5/91.16 5.48 (1.78 – 12.80) 1.00 (0.32 – 3.15)  0.999 
(χ2<0.01) 
0.86 (0.27 – 2.75) 0.799 
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Table II: Socio–demographic, behavioural and biological risk factors for HIV acquisition in women, overall and by sex work, Durban, South Africa, 2004/2007 




Cases/ PY  
at risk 
HIV Incidence  
(95% CI) 
Univariate 












HIV Incidence  
(95% CI) 
Univariate 










None or othera 8/108.16 7.40 (3.19 – 14.57) 1.33 (0.51 – 3.45)  0.558 
(χ2=0.34) 
1.51 (0.57 – 4.03) 0.411 
(χ2=0.68) 
6/88.32 6.79 (2.49 – 14.79) 1.24 (0.42 – 3.69)  0.699 
(χ2=0.15) 
1.52 (0.49 – 4.77) 0.469 
(χ2=0.52) 
Douching after sex       
No 24/356.29 6.73 (4.32 – 10.02) 1.00 –    18/280.89 6.41 (3.80 – 10.13) 1.00 –    
Yes 1/32.11 3.11 (0.08 – 17.35) 0.46 (0.06 – 3.40) 0.448 
(χ2=0.58) 
  0/25.99 0.00 –  –    
Sex after alcohol or substance use       
No 20/285.24 7.01 (4.28 – 10.83) 1.00  –    13/215.56 6.03 (3.21 – 10.31) 1.00  –    
Yes 5/103.98 4.81 (1.56 – 11.22) 0.68 (0.26 – 1.82) 0.447 
(χ2=0.58) 
  5/92.15 5.43 (1.76 – 12.66) 0.90 (0.32 – 2.51) 0.834 
(χ2=0.04) 
  
Sex for compensation       
Sex worker             
No 7/81.51 8.59 (3.45 – 17.69) 1.00  –          
Yes 18/307.71 5.85 (3.47 – 9.25) 0.68 (0.28 – 1.63) 0.390 
(χ2=0.74) 
        
Time in sex work (per 1 year increase) 0.93 (0.85 – 1.02) 0.126 
(χ2=2.34) 
    0.93 (0.85 – 1.02) 0.126 
(χ2=2.34) 
0.94 (0.85 – 1.05) 0.289 
(χ2=1.12) 
Age at start of sex work (per 1 year increase) 0.98 (0.93 – 1.04) 0.564 
(χ2=0.33) 
    0.98 (0.93 – 1.04) 0.564 
(χ2=0.33) 
  
Days per week perform sex work (Per 1 day increase) 1.08 (0.79 – 1.48) 0.648 
(χ2=0.21) 
    1.08 (0.79 – 1.48) 0.648 
(χ2=0.21) 
  
Number of sites per year (per 1 site increase) 1.12 (0.80 – 1.57) 0.503 
(χ2=0.45) 
    1.12 (0.80 – 1.57) 0.503 
(χ2=0.45) 
  
Clients per day (per 1 client increase) 1.10 (0.76 – 1.59) 0.628 
(χ2=0.23) 
    1.10 (0.76 – 1.59) 0.628 
(χ2=0.23) 
  
Clients past week (per 1 client increase) 0.93 (0.75 – 1.16) 0.536 
(χ2=0.38) 
    0.93 (0.75 – 1.16) 0.536 
(χ2=0.38) 
  
Short sessions per week (per 1 session increase) 0.97 (0.83 – 1.12) 0.651 
(χ2=0.20) 
    0.97 (0.83 – 1.12) 0.651 
(χ2=0.20) 
  
Overnight stays per week (per 1 stay increase) 1.33 (0.94 – 1.88) 0.106 
(χ2=2.61) 
    1.33 (0.94 – 1.88) 0.106 
(χ2=2.61) 
1.22 (0.84 – 1.77) 0.291 
(χ2=1.11) 
Condom use with client in the last month           
    Always                                   5/119.27 4.19 (1.36 – 9.78) 1.00 –    5/119.27 4.19 (1.36 – 9.78) 1.00 –    
Sometimes 9/132.17 6.81 (3.11 – 12.93) 1.61 (0.54 – 4.82) 0.391 
(χ2=0.74) 
  9/132.17 6.81 (3.11 – 12.93) 1.61 (0.54 – 4.82) 0.391 
(χ2=0.74) 
  
Never 4/56.27 7.11 (1.94 – 18.20) 1.68 (0.45 – 6.26) 0.440 
(χ2=0.60) 
  4/56.27 7.11 (1.94 – 18.20) 1.68 (0.45 – 6.26) 0.440 
(χ2=0.60) 
  
Clinical evaluation       
Ever pregnant prior to HIV       
No 22/342.24 6.43 (4.03 – 9.73) 1.00 –    22/342.24 5.89 (3.37 – 9.57) 1.00 –    
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Table II: Socio–demographic, behavioural and biological risk factors for HIV acquisition in women, overall and by sex work, Durban, South Africa, 2004/2007 




Cases/ PY  
at risk 
HIV Incidence  
(95% CI) 
Univariate 












HIV Incidence  
(95% CI) 
Univariate 









Yes 3/46.99 6.38 (1.32 – 18.66) 0.99 (0.30 – 3.32) 0.990 
(χ2<0.01) 
  2/36.15 5.53 (0.67 – 19.98) 0.93 (0.22 – 4.06) 0.927 
(χ2<0.01) 
  
Laboratory evaluations       
Sexually transmitted infectionb or bacterial vaginosis           
 No 5/148.75 3.36 (1.09 – 7.84) 1.00 –  1.00  4/116.34 3.44 (0.94 – 8.80) 1.00 –  1.00  
 Yes  20/238.49 8.39 (5.12 – 12.95) 2.47 (0.93 – 6.58) 0.071 
(χ2=3.26) 
2.49 (0.91 –  6.82) 0.077 
(χ2=3.13) 
14/189.38 7.39 (4.04 – 12.40) 2.13 (0.70 – 6.46) 0.184 
(χ2=1.77) 
1.89 (0.59 – 6.08) 0.287 
(χ2=1.14) 
a Female sterilisation or rhythm/calendar method 
b Any STI present if participant tested positive for syphilis antibodies or Trichomonas vaginalis, Neisseria gonorrhoeae, Mycoplasma genitalium, Chlamydia trachomatis or herpes simplex virus (HSV) 






In this study young age and having multiple sex partners were associated with risk of 
HIV acquisition. Despite the introduction of HIV prevention and treatment programmes, the 
HIV incidence rate of 7.2 per 100 wy remains unacceptably high. South Africa and many 
southern African countries continue to experience similar high HIV incidence rates (7, 10, 29, 
31, 32). Longitudinal studies among women in South Africa have shown HIV incidence rates 
of 6.6, 8.5 and 6.5 per 100 wy particularly amongst young women in the province of 
KwaZulu–Natal (7, 10, 29). Among pregnant women from the same region, HIV incidence 
was 10.7 per 100 wy (30). In Malawi and Zimbabwe, among women recruited from postnatal 
or family planning clinics, the HIV incidence rates were 4.20, 4.86 and 4.78 per 100 wy in 
Lilongwe, Blantyre and Harare respectively (31). Overall, the highest incidence rate of 5.78 
per 100 wy was among women younger than 25 years, whilst in Rwanda, among antenatal 
clinic attendees HIV incidence was 10.5 per 100 wy among women younger than 20 years 
(31, 32). These studies demonstrate young women’s vulnerability and greater risk of 
acquiring HIV compared to older women. Our study shows that young age carries a three–
fold greater risk of HIV acquisition.     
The importance of measuring HIV incidence is key to understanding the dynamics of 
HIV disease to shape and modify effective responses. The persistence of high HIV incidence 
rates and the vulnerability of young women is incompletely elucidated in this setting. Recent 
studies have shown that residing in urban informal settlements, being unmarried or 
unemployed was associated with higher HIV incidence highlighting the underlying structural 
and social factors driving the epidemic (5, 10). Although common in this setting, high risk 
behaviours such as engaging in age-disparate relationships, was not found to predict HIV risk 
in a population-based study and may be less likely to contribute to high HIV incidence in 
young women than previously thought (33). However, in this study we did not explore the 
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age of sexual partner as risk for HIV acquisition as risk through multiple partners with 
possible different ages is likely to be less apparent. Sexually transmitted infections are known 
to contribute to HIV risk in women in this region and ongoing research into the immunology 
of the female genital tract may provide further insight into the biological susceptibility to 
HIV infection particularly in young women (10, 20).   
 Although the vulnerability of young women is well recognised in this setting, risk for 
HIV is often underestimated since the perceived risk of HIV remains low (5). South Africa’s 
epidemic is generalised with HIV prevalence at an unprecedented high level, in excess of 
15% in the adult population, and new infection rates around 2% per year (5, 34). However, 
the majority of HIV–infected individuals are unaware of their HIV status, and this remains a 
barrier for both treatment access and prevention and helps sustain the epidemic. Poor 
knowledge of HIV transmission and limited access to and availability of health care services 
further promotes risk (5).  
Our study demonstrates that women in relationships with multiple partners were more 
likely to acquire HIV. While multiple concurrent partnerships is recognised as a key driver of 
the epidemic in the Southern African region, the total number of lifetime partners has also 
been found to be a significant predictor of HIV in this  region (12, 35). A meta–analysis of 68 
studies from sub–Saharan Africa assessing risk factors for HIV acquisition reported that the 
number of lifetime partners increased the risk of HIV by almost four–fold [Odds Ratio (OR) 
3.64, 95% CI 2.87–4.62] (35). In an urban mining community in Carletonville risk for HIV 
was almost five–fold higher in women reporting two or more lifetime partners (OR 4.88, 95% 
CI 3.01–7.89) (36). This risk was almost double for women reporting more than one partner 
three months prior to enrolment into HIV prevention intervention studies (adjusted OR 1.78, 
95% CI 1.11–2.85) and similar for young women 15 to 24 years (OR 2.0, 95% CI 1.1–3.7) 
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participating in the national household survey of South African youth, reporting more than 
one lifetime partner (4, 37).  
In this setting unemployment levels remain high and resources are constrained (9, 38). 
Marriage is also uncommon in this setting, leading to instability of relationships (9). 
Transactional sex, which may range from serial monogamous relationships to occasional 
exchange of sex for money or goods, provides a means of survival for women and their 
dependents, resulting in women engaging in multiple partnerships, either sequential or 
concurrent, in order to meet their basic needs (6, 9). Hence, emphasis and efforts on 
monogamy and multiple partner reduction cannot stand alone. The integration of structural 
approaches into current HIV policy, which address the socio-economic needs of women and 
which create an environment of equal opportunities and rights for women, is crucial if 
behavioural and biomedical prevention efforts are to succeed in the long-term.  
For female sex workers, increasing access to sexual and reproductive health services 
and sensitisation of service providers to sex worker vulnerability and health care need should 
be promoted. Increasing availability of condoms, reducing substance and alcohol use and 
access to multicomponent HIV prevention packages including ART as pre-exposure 
prophylaxis as a women initiated method of HIV prevention is key in this population if HIV 
incidence is to be reduced. Rigorously including HIV counselling and testing (HCT) across 
all levels is important and key to knowledge of HIV status. HCT is especially important to 
help people learn their own and their partners’ status so as to protect individuals whose 





The use of hormonal contraception was not found to be associated with HIV 
acquisition. Results from similar studies exploring the use of hormonal contraception 
increasing the risk of HIV acquisition remain inconsistent (21, 22, 27, 39). Major limitations 
of these studies have been the failure to test the hypotheses through robust study designs. 
Earlier studies showed some signals of an association between hormonal contraception and 
HIV acquisition (27). Similarly intra–vaginal insertion practices and pregnancy were not 
associated with HIV risk, though the outcome may be limited by the small sample size.  
Whilst elevated serum vitamin B12 levels was associated with HIV acquisition, its 
causal role requires further exploration. Recent evidence from critically ill elderly medical 
patients suggests that elevated serum vitamin B12 levels are associated with increased 
mortality (40, 41). Although increased levels have been associated with systemic 
inflammatory markers, its role in mediating HIV risk remains unclear (40). While genital 
tract inflammation associated with HIV risk in this cohort has been reported, the role of 
vitamin B12 as a marker of systemic inflammation and HIV risk requires further evaluation 
(20). 
The major strength of the study was the prospective cohort study design which 
allowed assessment of risk factors prior to HIV acquisition; however, there are several 
limitations as well. Firstly, participants had monthly study visits with risk reduction 
counselling, male and female condom provision, HIV testing with interviewer administered 
questionnaires; it is therefore possible that participants could have provided socially desirable 
responses given the sensitive nature of the sexual risk behaviour questions which could have 
biased the associations. Furthermore, given the wide age range of this cohort (18 to 58 years), 
it was difficult to adequately assess some risk behaviours which may be age dependent. 
Ideally, we would have liked to follow up behaviour in those women who remained HIV 
negative to assess HIV risk over time. Secondly, the small sample size of the study is an 
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important limitation, impacting on the precision of the study findings, therefore the 
particularly large confidences intervals around some of the point estimates. This may have 
also limited our ability to demonstrate stronger associations with some variables such as 
higher educational level and HIV acquisition and reduced HIV risk with every additional year 
spent in sex work. Thirdly, the recruitment of high risk women limits the generalizability of 
the study findings as these may not be representative of women from elsewhere in the 
province. Finally, as the study excluded women younger than 18 years, it was not possible to 
measure HIV incidence and risk factors in this young age group in whom HIV incidence is 
high (8). Whilst there are ethical challenges in conducting research in adolescents, it is 
important that young people, especially girls are included into research studies in order to 
better understand the high rates of HIV acquisition (8, 42). 
In conclusion, the findings of this study confirm that young women continue to bear 
the brunt of the HIV epidemic in this region. It is important that as transmission dynamics 
change over time, especially in hyperendemic settings, investments towards large–scale, 
fundamental changes in behaviour, social practices and community norms, address young 
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 Chapter 4: Discussion 
 
In this study we have shown that young age and having many partners placed women at 
increased risk for HIV infection. However, we were unable to demonstrate any association 
between other biological or behavioural factors such as hormonal contraception use, vaginal 
insertion practices and substance use with HIV. Among sex workers, no significant risk 
factors were identified related to sex work. These findings are however, subject to several 
limitations with regard to the internal validity and external validity of this retrospective 
analysis.  
Overall this study demonstrated an HIV incidence of 7.2 per 100 wy, similar to incidence 
rates of 6.6, 8.5 and 6.5 per 100 wy found in other studies in KwaZulu-Natal and elsewhere 
in Africa (6, 33, 35, 45, 130). The HIV incidence of 13.2 per 100 wy among women aged 18 
to 24 years was almost three-fold higher, as was risk for HIV acquisition, compared to 
women aged 25 years and older. These findings are consistent with earlier studies undertaken 
locally and in other African countries in which younger women were found to be most 
vulnerable to HIV infection (6, 33, 35, 45). The HSRC survey in South Africa found that 
young women aged between 15 and 24 years contributed almost a quarter of all new 
infections in 2012 (18). Antenatal prevalence surveys show similar results with HIV 
prevalence in the 15 to 24 year age group being 19.3% in the same reporting period (5). The 
high incidence of HIV particularly among adolescent girls is of particular concern, as current 
research, prevention and biomedical strategies are not inclusive of younger age groups, more 
importantly those less than 18 years of age, but remain at high risk for HIV acquisition (13). 
Highlighting the burden of disease in this age group is imperative to shift focus of prevention 




including HIV prevention programmes through school-based health services (131). A 
limitation to this analysis is that women younger than 18 years were not included in this 
study because of the ethical and regulatory challenges for the inclusion of adolescents in 
research studies, despite the increased risk of HIV in this group (132). It is now increasingly 
recognised that adolescents are able to and should be included in HIV prevention and 
treatment research activities if they are to benefit from such research (132, 133).  
This study also shows that women in relationships with multiple partners were at a higher 
risk for HIV acquisition. Although the percentage of women having multiple partners is 
reported to be around 8% for 15 to 24 year-old women and around 4% for women ≥25, 
having multiple concurrent partnerships or a high number of lifetime sexual partners 
increases women’s vulnerability to HIV in this setting (18, 31, 103, 109). Earlier studies and 
the HSRC survey found that women in non-stable partnerships had a considerably higher 
HIV incidence when compared to married women (18, 35, 37, 39). While reducing the 
number of sexual partners and promotion of stable partnerships, and possibly even marriage, 
should be included in HIV prevention messaging for women in the general population, this 
may not be a practical option for women such as female sex workers. Instead, increasing 
access to sexual and reproductive health services and sensitisation of service providers to sex 
worker vulnerability and health care need should be promoted. Knowledge of HIV status 
through frequent HIV testing, increasing availability of condoms, reducing substance and 
alcohol use and access to multicomponent HIV prevention packages including ART as pre-
exposure prophylaxis as a women initiated method of HIV prevention is key in this 
population if HIV incidence is to be reduced. 
As this particular cohort enrolled high risk women, defined by being a female sex workers or 




many partners and increased risk for HIV must be interpreted with caution as the inclusion 
criteria may have biased the association. Nevertheless, this association was strengthened 
when the analysis was restricted to sex workers only. This association did not remain 
significant in the overall multivariable analysis suggesting that this association may be 
explained partly by other demographic, behavioural or biological factors.  
A major strength of the study lies in the prospective cohort design which allowed us to assess 
risk factors prior to HIV acquisition in high risk women, wherein access to such groups is 
limited in this setting. Furthermore we were able to demonstrate that even among high risk 
women, young age is a risk factor for HIV with high HIV incidence rates. It is also important 
to note that almost 60% of women were ineligible for study participation due to being HIV 
seropositive at screening and only a third of those screened were eligible to enrol. A 
subgroup analysis of those excluded further showed the high burden of prevalent infections 
in young women although risk behaviour of women who screened out may have differed 
substantially from women enrolled into the study. Nevertheless the prevalence in women 
screened out and the high HIV incidence rates demonstrate the impact of HIV, more 
importantly in young women.     
An important consideration in this secondary analysis is the age of the dataset. This study 
enrolled women between August 2004 and May 2005, at a time when HIV prevention and 
treatment services were limited and at a time when HIV stigma and discrimination were 
likely to be more common. Women participating in this study may have actively sought HIV 
prevention services and we may have therefore selected a cohort of women with health 
seeking behaviour or who engage in risky behaviour more frequently. Furthermore, since the 
introduction of ART only began around 2004, the benefits of expanded ART coverage on 




more recent studies undertaken in KwaZulu-Natal indicate no significant declines in HIV 
incidence in women following scale-up of ART services (6, 13).  
As risk behaviour questionnaires were interviewer-administered and women were provided 
with risk reduction counselling, condoms and HIV testing at each study visit, the reported 
responses may have resulted in social desirability bias and may have influenced the 
responses to questions on risk behaviour. Women may have under-reported sexual activity 
and high risk sexual behaviours, particularly those women not self-identifying as female sex 
workers. Furthermore, observer or interviewer bias was also introduced as interviewers were 
aware of the participants’ sex worker status and this may have influenced the capture of 
responses as well. These biases could have been minimised had the questionnaires been self-
administered and anonymous. As risk behaviour questionnaires were administered at baseline 
only, we were unable to assess changes in risk behaviour over time. Importantly it would 
have been useful to assess the temporal association of risk behaviours at follow up visits for 
women who remained HIV negative.  
The small sample size of the study is an important limitation, impacting on the precision of 
the study findings, therefore the particularly large confidences intervals around the point 
estimates. While there were weak associations identified such as increased risk for HIV with 
a higher level of education, these findings were not found to be statistically significant. 
Furthermore, the small sample size may not have allowed us to adequately assess other 
variables such as delayed sexual debut and HIV risk.  
There are several possible confounding variables which may have impacted the analysis of 
data. Sexually transmitted infections have been evaluated in a separate analysis and was 
found to increase risk for HIV overall by three-fold (73). This variable, because of its 




analysis. Host genetic and immunological factors that were not included in the multivariable 
analysis, some of which include TRIM5αhu, Interleukin-10 and Duffy-null-associated low 
neutrophil count trait, were previously found to reduce risk for HIV in this cohort (84-86). 
Viral factors were also not accounted for in this analysis. Furthermore, from laboratory 
evaluations, some variables were found to be significantly different between women who 
acquired HIV and those who did not e.g. vitamin B12 and serum sodium were raised among 
women who acquired HIV while random glucose levels were lower in the same group. These 
variables were not included in the multivariable analysis as the clinical significance and 
biological plausibility of these findings are uncertain. However, better designed studies are 
needed to further explore these variables and HIV risk.  
As large proportion of women in this cohort were self-reported female sex workers and were 
recruited from a very specific geographical location in KwaZulu-Natal province, the external 
validity or generalisability of this cohort is limited to similar high risk women from the same 
region. Furthermore the study enrolled women with HIV-1 subtype C infection which makes 
the findings less generalisable to regions with other HIV subtypes. Results from this study 
may not be extrapolated to other areas in KwaZulu-Natal province or elsewhere in South 
Africa as this is a very well defined cohort in an urban setting. Nevertheless, this high risk 
cohort provides useful information which may be compared with other high risk cohorts in 
South Africa and in other regions in Africa. 
Notwithstanding these limitations, the study remains relevant as the province of KwaZulu-
Natal remains a region of highly burdened by HIV and knowledge of risk behaviour among 







Chapter 5: Conclusion and Implications for Future Research and 
Policy 
 
This research highlights the following key findings and recommendations for policy and 
future research undertaken: 
 
• Young women in the province of KwaZulu-Natal bear a high burden of HIV 
infection, even amongst high risk groups.  
• This study confirms that having multiple partners contributes to enhancing HIV risk 
in this setting.  
• As HIV prevention technologies for women remain limited in this setting, enhancing 
currently available multicomponent HIV prevention packages including HIV testing 
with counselling, increasing male and female condom use and reducing substance and 
alcohol use are important tools for preventing HIV acquisition. Access to ART as pre-
exposure prophylaxis when licenced and available for public sector use should be 
promoted as a women initiated method to prevent HIV acquisition.   
• ART programmes through early initiation of treatment at higher CD4+ cell counts and 
expanded ART coverage through existing services provide substantial benefit by 
reducing HIV related morbidity at the individual level and more importantly impact on 
HIV incidence at a population level over the long-term.  
• As newer HIV prevention tools are developed, such as long acting injectable ART for 
pre-exposure prophylaxis, which are still in the early phases of research, these may 




• For women engaging in sex work emphasis and efforts on safer sex practices, easy 
access to sexual and reproductive health services and in the long-term, social and 
economic upliftment of women, remain key priorities.  
• For future studies assessing risk factors for HIV acquisition in women, we 
recommend that younger adolescent women be included as they are becoming 
increasingly more vulnerable to HIV infection and knowledge of HIV risk in this group 
is critical to informing targeted HIV prevention programmes. Furthermore assessing risk 
over time is imperative as risk behaviour evolves over time.  
• The role of vitamin B12 as a marker of systemic inflammation requires further 
exploration in this cohort. Ongoing research to better understand immunological and 
biological responses in  the female genital tract will be key to provide greater insight into 






Chapter 6: References 
 
 
1. Avert. History of AIDS up to 1986. Available from: http://www.avert.org/aids-
history-86.htm. Accessed March 19, 2013. 
2. WHO. Global Health Observatory: HIV/AIDS. Available from: 
http://www.who.int/gho/hiv/en/. Accessed August 29, 2014. 
3. Fauci AS, Morens DM. The perpetual challenge of infectious diseases. N Engl J Med. 
2012;366(5):454-61. 
4. Abdool Karim Q, Kharsany ABM. Epidemiology of HIV/AIDS. In: Hall JC, Hall BJ 
& Cockerell CJ, eds. HIV/AIDS in the Post-HAART Era: Manifestations,Treatment, 
and Epidemiology. People's Medical Publishing House -USA; 2011. 
5. National Department of Health. The 2012 National Antenatal Sentinel HIV and 
Herpes Simplex type-2 prevalence Survey, South Africa. Available from: 
http://www.health-e.org.za/wp-
content/uploads/2014/05/ASHIVHerp_Report2014_22May2014.pdf. Accessed July 
14, 2014. 
6. Abdool Karim Q, Kharsany ABM, Frohlich JA, Werner L, Mashego M, Mlotshwa M, 
et al. Stabilizing HIV prevalence masks high HIV incidence rates amongst rural and 
urban women in KwaZulu-Natal, South Africa. Int J Epidemiol. 2011;40(4):922-30. 





idemiology/2013/gr2013/UNAIDS_Global_Report_2013_en.pdf. Accessed April 22, 
2014. 
8. WHO, UNAIDS and UNICEF. Global HIV/AIDS Response. Epidemic update and 
health sector progress towards Universal Access. Progress Report 2011. Available 
from: http://www.who.int/hiv/pub/progress_report2011/hiv_full_report_2011.pdf. 
Accessed August 12, 2013. 
9. Kharsany ABM, Abdool Karim Q. HIV Epidemiology and Prevention. In: Barros E, 
ed. Tech-HIV-infection - Impact, Awareness and Social Implications of living with 
HIV/AIDS. InTech; 2011. 
10. Abdool Karim Q, Humphries H. Reducing HIV Infection in Young Women in 
Southern Africa: The Key to Altering Epidemic Trajectories in a Generalised 
Hyperendemic Setting. Available from: http://www.aidstar-
one.com/sites/default/files/additional_resources/AIDSTAR-
One_Pev_Spotlight_Issue_3.pdf. Accessed March 12, 2013. 
11. Mastro TD, Kim AA, Hallett T, Rehle T, Welte A, Laeyendecker O, et al. Estimating 
HIV Incidence in Populations Using Tests for Recent Infection: Issues, Challenges 
and the Way Forward. Journal of HIV AIDS surveillance & epidemiology. 
2010;2(1):1-14. 
12. Simelela NP, Venter WD. A brief history of South Africa's response to AIDS. S Afr 
Med J. 2014;104(3 Suppl 1):249-51. 
13. Abdool Karim Q, Kharsany ABM, Frohlich JA, Werner L, Mlotshwa M, Madlala BT, 




imperative for their inclusion in HIV biomedical intervention trials. AIDS Behav. 
2012;16(7):1870-6. 
14. Nel A, Mabude Z, Smit J, Kotze P, Arbuckle D, Wu J, et al. HIV incidence remains 
high in KwaZulu-Natal, South Africa: evidence from three districts. PLoS One. 
2012;7(4):e35278. 
15. Kelly K, Mkhwanazi N, Nkhwashu N, Rapiti R, Mashale R. (2012) HIV prevention 
situation analysis in KwaZulu-Natal, Mpumalanga and Gauteng provinces, South 
Africa. USAID Sexual HIV Prevention Programme in South Africa (SHIPP). 
Available from: 
http://futuresgroup.com/files/publications/Synthesis_of_Research_on_Prevention_of_
Sexual_Transmission_of_HIV_in_SA.pdf. Accessed March 20, 2013. 
16. Ghys PD, Kufa E, George MV. Measuring trends in prevalence and incidence of HIV 
infection in countries with generalised epidemics. Sex Transm Infect. 2006;82 Suppl 
1:i52-6. 
17. Rehle TM, Hallett TB, Shisana O, Pillay-van Wyk V, Zuma K, Carrara H, et al. A 
decline in new HIV infections in South Africa: estimating HIV incidence from three 
national HIV surveys in 2002, 2005 and 2008. PLoS One. 2010;5(6):e11094. 
18. Shisana O, Rehle, T, Simbayi LC, Zuma, K, Jooste, S, Zungu N, Labadarios, D, 
Onoya, D. et al. South African National HIV Prevalence, Incidence and Behaviour 
Survey, 2012. Cape Town: HSRC Press; 2014. 
19. Gupta GR, Parkhurst JO, Ogden JA, Aggleton P, Mahal A. Structural approaches to 




20. Poundstone KE, Strathdee SA, Celentano DD. The social epidemiology of human 
immunodeficiency virus/acquired immunodeficiency syndrome. Epidemiol Rev. 
2004;26:22-35. 
21. Abdool Karim Q, Abdool Karim SS. The evolving HIV epidemic in South Africa. Int 
J Epidemiol. 2002;31(1):37-40. 
22. Centers for Disease Control and Prevention. HIV among African Americans. 
Available from: http://www.cdc.gov/hiv/risk/racialethnic/aa/facts/. Accessed August 
02, 2014. 
23. Nattrass N. Poverty, sex and HIV. AIDS Behav. 2009;13(5):833-40. 
24. WHO. HIV/AIDS. Available from: 
http://www.who.int/immunization/topics/hiv/en/index1.html. Accessed March 02, 
2014. 
25. Centers for Disease Control and Prevention. HIV among women. Available from: 
http://www.cdc.gov/HIV/risk/gender/women/facts/index.html. Accessed August 02, 
2014. 
26. Wojcicki JM. Socioeconomic status as a risk factor for HIV infection in women in 
East, Central and Southern Africa: a systematic review. J Biosoc Sci. 2005;37(1):1-
36. 
27. Pettifor AE, Levandowski BA, MacPhail C, Padian NS, Cohen MS, Rees HV. Keep 
them in school: the importance of education as a protective factor against HIV 




28. Statistics South Africa. Available from: http://beta2.statssa.gov.za/. Accessed 
September 07, 2014. 
29. Lurie MN, Williams BG, Zuma K, Mkaya-Mwamburi D, Garnett G, Sturm AW, et al. 
The impact of migration on HIV-1 transmission in South Africa: a study of migrant 
and nonmigrant men and their partners. Sex Transm Dis. 2003;30(2):149-56. 
30. Camlin CS, Hosegood V, Newell ML, McGrath N, Barnighausen T, Snow RC. 
Gender, migration and HIV in rural KwaZulu-Natal, South Africa. PLoS One. 
2010;5(7):e11539. 
31. Zuma K, Gouws E, Williams B, Lurie M. Risk factors for HIV infection among 
women in Carletonville, South Africa: migration, demography and sexually 
transmitted diseases. Int J STD AIDS. 2003;14(12):814-7. 
32. Barnighausen T, Hosegood V, Timaeus IM, Newell ML. The socioeconomic 
determinants of HIV incidence: evidence from a longitudinal, population-based study 
in rural South Africa. AIDS. 2007;21 Suppl 7:S29-38. 
33. Wand H, Ramjee G. Combined impact of sexual risk behaviors for HIV 
seroconversion among women in Durban, South Africa: implications for prevention 
policy and planning. AIDS Behav. 2011;15(2):479-86. 
34. Kongnyuy EJ, Soskolne V, Adler B. Hormonal contraception, sexual behaviour and 
HIV prevalence among women in Cameroon. BMC Womens Health. 2008;8:19. 
35. Kumwenda N, Hoffman I, Chirenje M, Kelly C, Coletti A, Ristow A, et al. HIV 





36. Geis S, Maboko L, Saathoff E, Hoffmann O, Geldmacher C, Mmbando D, et al. Risk 
factors for HIV-1 infection in a longitudinal, prospective cohort of adults from the 
Mbeya Region, Tanzania. J Acquir Immune Defic Syndr. 2011;56(5):453-9. 
37. Hattingh Z. Socio-demographic risk factors for HIV infection in women living in 
Mangaung, Free state. S Afr J Clin Nutr. 2009;22(4):203-7. 
38. Naidoo P, Chirinda W, McHunu G, Swartz S, Anderson J. Social and structural 
factors associated with vulnerability to HIV infection among young adults in South 
Africa. Psychology, health & medicine. 2014,Jul 15:1-11. 
39. Barnighausen T, Tanser F, Gqwede Z, Mbizana C, Herbst K, Newell ML. High HIV 
incidence in a community with high HIV prevalence in rural South Africa: findings 
from a prospective population-based study. AIDS. 2008;22(1):139-44. 
40. Santelli JS, Edelstein ZR, Mathur S, Wei Y, Zhang W, Orr MG, et al. Behavioral, 
biological, and demographic risk and protective factors for new HIV infections 
among youth in Rakai, Uganda. J Acquir Immune Defic Syndr. 2013;63(3):393-400. 
41. Santelli JS, Edelstein ZR, Wei Y, Mathur S, Song X, Schuyler A, et al. Trends in HIV 
acquisition, risk factors and prevention policies among youth in Uganda, 1999-2011. 
AIDS. 2015;29(2):211-9. 
42. Clark S, Bruce J, Dude A. Protecting young women from HIV/AIDS: the case against 





43. Nyamhanga TM, Frumence G. Gender context of sexual violence and HIV sexual risk 
behaviors among married women in Iringa Region, Tanzania. Global health action. 
2014;7:25346. 
44. Ruzagira E, Wandiembe S, Abaasa A, Bwanika AN, Bahemuka U, Amornkul P, et al. 
HIV incidence and risk factors for acquisition in HIV discordant couples in Masaka, 
Uganda: an HIV vaccine preparedness study. PLoS One. 2011;6(8):e24037. 
45. Bulterys M, Chao A, Habimana P, Dushimimana A, Nawrocki P, Saah A. Incident 
HIV-1 infection in a cohort of young women in Butare, Rwanda. AIDS. 
1994;8(11):1585-91. 
46. Abdool Karim Q, Sibeko S, Baxter C. Preventing HIV infection in women: a global 
health imperative. Clin Infect Dis. 2010;50 Suppl 3:S122-9. 
47. Nicolosi A, Correa Leite ML, Musicco M, Arici C, Gavazzeni G, Lazzarin A. The 
efficiency of male-to-female and female-to-male sexual transmission of the human 
immunodeficiency virus: a study of 730 stable couples. Italian Study Group on HIV 
Heterosexual Transmission. Epidemiology. 1994;5(6):570-5. 
48. Padian NS, Shiboski SC, Jewell NP. Female-to-male transmission of human 
immunodeficiency virus. Jama. 1991;266(12):1664-7. 
49. Kingsley LA, Detels R, Kaslow R, Polk BF, Rinaldo CR, Jr., Chmiel J, et al. Risk 
factors for seroconversion to human immunodeficiency virus among male 





50. Winkelstein W, Jr., Lyman DM, Padian N, Grant R, Samuel M, Wiley JA, et al. 
Sexual practices and risk of infection by the human immunodeficiency virus. The San 
Francisco Men's Health Study. Jama. 1987;257(3):321-5. 
51. Detels R, English P, Visscher BR, Jacobson L, Kingsley LA, Chmiel JS, et al. 
Seroconversion, sexual activity, and condom use among 2915 HIV seronegative men 
followed for up to 2 years. J Acquir Immune Defic Syndr. 1989;2(1):77-83. 
52. Abdool Karim SS, Ramjee G. Anal sex and HIV transmission in women. Am J Public 
Health. 1998;88(8):1265 - 6. 
53. Lifson AR, O'Malley PM, Hessol NA, Buchbinder SP, Cannon L, Rutherford GW. 
HIV seroconversion in two homosexual men after receptive oral intercourse with 
ejaculation: implications for counseling concerning safe sexual practices. Am J Public 
Health. 1990;80(12):1509-11. 
54. Gray RH, Wawer MJ, Brookmeyer R, Sewankambo NK, Serwadda D, Wabwire-
Mangen F, et al. Probability of HIV-1 transmission per coital act in monogamous, 
heterosexual, HIV-1-discordant couples in Rakai, Uganda. Lancet. 
2001;357(9263):1149-53. 
55. Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, 
et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 
2011;365(6):493-505. 
56. Nel JT. Ectopy and related conditions of the cervix. In: Nel JT, ed. Core Obstetrics 




57. Critchlow CW, Wolner-Hanssen P, Eschenbach DA, Kiviat NB, Koutsky LA, 
Stevens CE, et al. Determinants of cervical ectopia and of cervicitis: age, oral 
contraception, specific cervical infection, smoking, and douching. Am J Obstet 
Gynecol. 1995;173(2):534-43. 
58. Bright PL, Norris Turner A, Morrison CS, Wong EL, Kwok C, Yacobson I, et al. 
Hormonal contraception and area of cervical ectopy: a longitudinal assessment. 
Contraception. 2011;84(5):512-9. 
59. Myer L, Wright TC, Jr., Denny L, Kuhn L. Nested case-control study of cervical 
mucosal lesions, ectopy, and incident HIV infection among women in Cape Town, 
South Africa. Sex Transm Dis. 2006;33(11):683-7. 
60. Moss GB, Clemetson D, D'Costa L, Plummer FA, Ndinya-Achola JO, Reilly M, et al. 
Association of cervical ectopy with heterosexual transmission of human 
immunodeficiency virus: results of a study of couples in Nairobi, Kenya. J Infect Dis. 
1991;164(3):588-91. 
61. Venkatesh KK, Cu-Uvin S. Assessing the relationship between cervical ectopy and 
HIV susceptibility: implications for HIV prevention in women. Am J Reprod 
Immunol. 2013;69 Suppl 1:68-73. 
62. Mugo NR, Heffron R, Donnell D, Wald A, Were EO, Rees H, et al. Increased risk of 
HIV-1 transmission in pregnancy: a prospective study among African HIV-1-




63. Gray RH, Li X, Kigozi G, Serwadda D, Brahmbhatt H, Wabwire-Mangen F, et al. 
Increased risk of incident HIV during pregnancy in Rakai, Uganda: a prospective 
study. Lancet. 2005;366(9492):1182-8. 
64. Morrison CS, Wang J, Van Der Pol B, Padian N, Salata RA, Richardson BA. 
Pregnancy and the risk of HIV-1 acquisition among women in Uganda and 
Zimbabwe. AIDS. 2007;21(8):1027-34. 
65. Reid SE, Dai JY, Wang J, Sichalwe BN, Akpomiemie G, Cowan FM, et al. 
Pregnancy, contraceptive use, and HIV acquisition in HPTN 039: relevance for HIV 
prevention trials among African women. J Acquir Immune Defic Syndr. 
2010;53(5):606-13. 
66. Hel Z, Stringer E, Mestecky J. Sex steroid hormones, hormonal contraception, and 
the immunobiology of human immunodeficiency virus-1 infection. Endocr Rev. 
2010;31(1):79-97. 
67. Heffron R, Donnell D, Rees H, Celum C, Mugo N, Were E, et al. Use of hormonal 
contraceptives and risk of HIV-1 transmission: a prospective cohort study. Lancet 
Infect Dis. 2012;12(1):19-26. 
68. Morrison CS, Skoler-Karpoff S, Kwok C, Chen PL, van de Wijgert J, Gehret-
Plagianos M, et al. Hormonal contraception and the risk of HIV acquisition among 
women in South Africa. AIDS. 2012;26(4):497-504. 
69. Polis CB, Curtis KM. Use of hormonal contraceptives and HIV acquisition in women: 





70. Fleming DT, Wasserheit JN. From epidemiological synergy to public health policy 
and practice: the contribution of other sexually transmitted diseases to sexual 
transmission of HIV infection. Sex Transm Infect. 1999;75(1):3-17. 
71. Salvana EMT. HIV and STIs: Interactions in resource-limited settings. Available 
from: http://www.medscape.com/viewarticle/754637. Accessed March 12, 2014. 
72. Brown JM, Wald A, Hubbard A, Rungruengthanakit K, Chipato T, Rugpao S, et al. 
Incident and prevalent herpes simplex virus type 2 infection increases risk of HIV 
acquisition among women in Uganda and Zimbabwe. AIDS. 2007;21(12):1515-23. 
73. Mlisana K, Naicker N, Werner L, Roberts L, van Loggerenberg F, Baxter C, et al. 
Symptomatic vaginal discharge is a poor predictor of sexually transmitted infections 
and genital tract inflammation in high-risk women in South Africa. J Infect Dis. 
2012;206(1):6-14. 
74. Kapiga S, Kelly C, Weiss S, Daley T, Peterson L, Leburg C, et al. Risk factors for 
incidence of sexually transmitted infections among women in South Africa, Tanzania, 
and Zambia: results from HPTN 055 study. Sex Transm Dis. 2009;36(4):199-206. 
75. Atashili J, Poole C, Ndumbe P, Adimora A, Smith J. Bacterial vaginosis and HIV 
acquisition: a meta-analysis of published studies. AIDS. 2008;22(12):1493-501. 
76. Grosskurth H, Mosha F, Todd J, Mwijarubi E, Klokke A, Senkoro K, et al. Impact of 
improved treatment of sexually transmitted diseases on HIV infection in rural 
Tanzania: randomised controlled trial. Lancet. 1995;346(8974):530-6. 
77. Kamali A, Quigley M, Nakiyingi J, Kinsman J, Kengeya-Kayondo J, Gopal R, et al. 




interventions on transmission of HIV-1 in rural Uganda: a community randomised 
trial. Lancet. 2003;361(9358):645-52. 
78. Wawer MJ, Sewankambo NK, Serwadda D, Quinn TC, Paxton LA, Kiwanuka N, et 
al. Control of sexually transmitted diseases for AIDS prevention in Uganda: a 
randomised community trial. Rakai Project Study Group. Lancet. 
1999;353(9152):525-35. 
79. Grosskurth H, Gray R, Hayes R, Mabey D, Wawer M. Control of sexually transmitted 
diseases for HIV-1 prevention: understanding the implications of the Mwanza and 
Rakai trials. Lancet. 2000;355(9219):1981-7. 
80. White RG, Orroth KK, Korenromp EL, Bakker R, Wambura M, Sewankambo NK, et 
al. Can population differences explain the contrasting results of the Mwanza, Rakai, 
and Masaka HIV/sexually transmitted disease intervention trials?: A modeling study. 
J Acquir Immune Defic Syndr. 2004;37(4):1500-13. 
81. HIV Gene. What is CCR5? Available from: http://www.hivgene.com/what-is-
ccr5.php. Accessed February 03, 2014. 
82. Klein MR, van der Burg SH, Hovenkamp E, Holwerda AM, Drijfhout JW, Melief CJ, 
et al. Characterization of HLA-B57-restricted human immunodeficiency virus type 1 
Gag- and RT-specific cytotoxic T lymphocyte responses. J Gen Virol. 1998;79 ( Pt 
9):2191-201. 
83. Itescu S, Mathur-Wagh U, Skovron ML, Brancato LJ, Marmor M, Zeleniuch-
Jacquotte A, et al. HLA-B35 is associated with accelerated progression to AIDS. J 




84. Sewram S, Singh R, Kormuth E, Werner L, Mlisana K, Abdool Karim SS, et al. 
Human TRIM5alpha expression levels and reduced susceptibility to HIV-1 infection. 
J Infect Dis. 2009;199(11):1657-63. 
85. Naicker DD, Werner L, Kormuth E, Passmore JA, Mlisana K, Abdool Karim SS, et 
al. Interleukin-10 promoter polymorphisms influence HIV-1 susceptibility and 
primary HIV-1 pathogenesis. J Infect Dis. 2009;200(3):448-52. 
86. Ramsuran V, Kulkarni H, He W, Mlisana K, Wright EJ, Werner L, et al. Duffy-null-
associated low neutrophil counts influence HIV-1 susceptibility in high-risk South 
African black women. Clin Infect Dis. 2011;52(10):1248-56. 
87. Levy JA. Pathogenesis of human immunodeficiency virus infection. Microbiol Rev. 
1993;57(1):183-289. 
88. Achhra A, Amin J. Race and CD4+ T cell count in HIV prognosis and treatment. 
Future Virology. 2012;7(2):193-203. 
89. van Asten L, Danisman F, Otto SA, Borghans JA, Hazenberg MD, Coutinho RA, et 
al. Pre-seroconversion immune status predicts the rate of CD4 T cell decline 
following HIV infection. AIDS. 2004;18(14):1885-93. 
90. Mehendale SM, Shepherd ME, Brookmeyer RS, Semba RD, Divekar AD, 
Gangakhedkar RR, et al. Low carotenoid concentration and the risk of HIV 
seroconversion in Pune, India. J Acquir Immune Defic Syndr. 2001;26(4):352-9. 
91. Szerlip MA, DeSalvo KB, Szerlip HM. Predictors of HIV-infection in older adults. J 




92. Moore PS, Allen S, Sowell AL, Van de Perre P, Huff DL, Serufilira A, et al. Role of 
nutritional status and weight loss in HIV seroconversion among Rwandan women. J 
Acquir Immune Defic Syndr. 1993;6(6):611-6. 
93. MacDonald KS, Malonza I, Chen DK, Nagelkerke NJ, Nasio JM, Ndinya-Achola J, et 
al. Vitamin A and risk of HIV-1 seroconversion among Kenyan men with genital 
ulcers. AIDS. 2001;15(5):635-9. 
94. Hilber AM, Chersich MF, van de Wijgert JH, Rees H, Temmerman M. Vaginal 
practices, microbicides and HIV: what do we need to know? Sex Transm Infect. 
2007;83(7):505-8. 
95. WHO. Preventing HIV among sex workers in sub-Saharan Africa: A literature 
review. Available from: 
http://whqlibdoc.who.int/publications/2011/9789241501279_eng.pdf. Accessed 
January 24, 2014. 
96. Mavedzenge SN, Weiss HA, Montgomery ET, Blanchard K, de Bruyn G, Ramjee G, 
et al. Determinants of differential HIV incidence among women in three southern 
African locations. J Acquir Immune Defic Syndr. 2011;58(1):89-99. 
97. Pettifor A, O'Brien K, Macphail C, Miller WC, Rees H. Early coital debut and 
associated HIV risk factors among young women and men in South Africa. Int 
Perspect Sex Reprod Health. 2009;35(2):82-90. 
98. Wand H, Ramjee G. The relationship between age of coital debut and HIV 





99. Akileswaran C, Lurie MN. Understanding age-disparate relationships and HIV/AIDS 
among young women in sub-Saharan Africa: a sytematic review. AIDS 2006 - XVI 
International AIDS Conference. Toronto, 2006 [Abstract no. WEPE0713]. 
100. Pettifor AE, Rees HV, Kleinschmidt I, Steffenson AE, MacPhail C, Hlongwa-
Madikizela L, et al. Young people's sexual health in South Africa: HIV prevalence 
and sexual behaviors from a nationally representative household survey. AIDS. 
2005;19(14):1525-34. 
101. Harling G, Newell ML, Tanser F, Kawachi I, Subramanian SV, Barnighausen T. Do 
Age-Disparate Relationships Drive HIV Incidence in Young Women? Evidence from 
a Population Cohort in Rural KwaZulu-Natal, South Africa. J Acquir Immune Defic 
Syndr. 2014;66(4):443-51. 
102. Leclerc-Madlala S. Age-disparate and intergenerational sex in southern Africa: the 
dynamics of hypervulnerability. AIDS. 2008;22 Suppl 4:S17-25. 
103. Chen L, Jha P, Stirling B, Sgaier SK, Daid T, Kaul R, et al. Sexual risk factors for 
HIV infection in early and advanced HIV epidemics in sub-Saharan Africa: 
systematic overview of 68 epidemiological studies. PLoS One. 2007;2(10):e1001. 
104. Onoya D, Reddy P, Sifunda S, Lang D, Wingood GM, van den Borne B, et al. 
Transactional sexual relationships, sexually transmitted infection risk, and condom 
use among young Black Women in peri-urban areas of the Western Cape Province of 




105. Dunkle KL, Jewkes RK, Brown HC, Gray GE, McIntryre JA, Harlow SD. 
Transactional sex among women in Soweto, South Africa: prevalence, risk factors 
and association with HIV infection. Soc Sci Med. 2004;59(8):1581-92. 
106. South African National AIDS Council. National Strategic Plan for HIV Prevention, 
Care and Treatment for Sex Workers. 2013. Pretoria, South Africa. 
107. Dunkle KL, Beksinska ME, Rees VH, Ballard RC, Htun Y, Wilson ML. Risk factors 
for HIV infection among sex workers in Johannesburg, South Africa. Int J STD 
AIDS. 2005;16(3):256-61. 
108. Varga CA. Coping with HIV/AIDS in Durban's commercial sex industry. AIDS Care. 
2001;13(3):351-65. 
109. Halperin DT. Why is HIV prevalence so severe in Southern Africa? The Southern 
African Journal of HIV Medicine. 2007;8(1):19-25. 
110. Steffenson AE, Pettifor AE, Seage GR, 3rd, Rees HV, Cleary PD. Concurrent sexual 
partnerships and human immunodeficiency virus risk among South African youth. 
Sex Transm Dis. 2011;38(6):459-66. 
111. Wilkinson D. Condom effectiveness in reducing heterosexual HIV transmission: RHL 
commentary (last revised: 11 November 2002). The WHO Reproductive Health 
Library; Geneva: World Health Organisation. Available from: 
http://apps.who.int/rhl/hiv_aids/dwcom/en/. Accessed March 20, 2013. 
112. van Loggerenberg F, Dieter AA, Sobieszczyk ME, Werner L, Grobler A, Mlisana K. 
HIV prevention in high-risk women in South Africa: condom use and the need for 




113. Kalichman SC, Simbayi LC, Kaufman M, Cain D, Jooste S. Alcohol use and sexual 
risks for HIV/AIDS in sub-Saharan Africa: systematic review of empirical findings. 
Prev Sci. 2007;8(2):141-51. 
114. Pithey A, Parry C. Descriptive systematic review of Sub-Saharan African studies on 
the association between alcohol use and HIV infection. Sahara J. 2009;6(4):155-69. 
115. Browne FA, Wechsberg WM. The intersecting risks of substance use and HIV risk 
among substance-using South African men and women. Curr Opin Psychiatry. 
2010;23(3):205-9. 
116. Parry C, Petersen P, Carney T, Dewing S, Needle R. Rapid assessment of drug use 
and sexual HIV risk patterns among vulnerable drug-using populations in Cape 
Town, Durban and Pretoria, South Africa. Sahara J. 2008;5(3):113-9. 
117. Priddy FH, Wakasiaka S, Hoang TD, Smith DJ, Farah B, del Rio C, et al. Anal sex, 
vaginal practices, and HIV incidence in female sex workers in urban Kenya: 
implications for the development of intravaginal HIV prevention methods. AIDS Res 
Hum Retroviruses. 2011;27(10):1067-72. 
118. Turner AN, Morrison CS, Munjoma MW, Moyo P, Chipato T, van de Wijgert JH. 
Vaginal practices of HIV-negative Zimbabwean women. Infect Dis Obstet Gynecol. 
DOI 10.1155/2010/387671.Epub 24 Aug 2010. 
119. Scorgie F, Smit JA, Kunene B, Martin-Hilber A, Beksinska M, Chersich MF. 
Predictors of vaginal practices for sex and hygiene in KwaZulu-Natal, South Africa: 





120. Smit J, Chersich MF, Beksinska M, Kunene B, Manzini N, Hilber AM, et al. 
Prevalence and self-reported health consequences of vaginal practices in KwaZulu-
Natal, South Africa: findings from a household survey. Trop Med Int Health. 
2011;16(2):245-56. 
121. McClelland RS, Lavreys L, Hassan WM, Mandaliya K, Ndinya-Achola JO, Baeten 
JM. Vaginal washing and increased risk of HIV-1 acquisition among African women: 
a 10-year prospective study. AIDS. 2006;20(2):269-73. 
122. van de Wijgert JH, Morrison CS, Cornelisse PG, Munjoma M, Moncada J, Awio P, et 
al. Bacterial vaginosis and vaginal yeast, but not vaginal cleansing, increase HIV-1 
acquisition in African women. J Acquir Immune Defic Syndr. 2008;48(2):203-10. 
123. Myer L, Denny L, de Souza M, Wright TC, Jr., Kuhn L. Distinguishing the temporal 
association between women's intravaginal practices and risk of human 
immunodeficiency virus infection: a prospective study of South African women. Am 
J Epidemiol. 2006;163(6):552-60. 
124. McClelland RS, Richardson BA, Graham SM, Masese LN, Gitau R, Lavreys L, et al. 
A prospective study of risk factors for bacterial vaginosis in HIV-1-seronegative 
African women. Sex Transm Dis. 2008;35(6):617-23. 
125. Iliyasu Z, Abubakar IS, Kabir M, Aliyu MH. Knowledge of HIV/AIDS and attitude 





126. Hentgen V, Jaureguiberry S, Ramiliarisoa A, Andrianantoandro V, Belec M. 
Knowledge, attitude and practices of health personnel with regard to HIV/AIDS in 
Tamatave (Madagascar). Bull Soc Pathol Exot. 2002;95(2):103-8. 
127. Ochako R, Ulwodi D, Njagi P, Kimetu S, Onyango A. Trends and determinants of 
Comprehensive HIV and AIDS knowledge among urban young women in Kenya. 
AIDS Res Ther. 2011;8:11. 
128. Brewer DD. Knowledge of blood-borne transmission risk is inversely associated with 
HIV infection in sub-Saharan Africa. J Infect Dev Ctries. 2011;5(3):182-98. 
129. Peltzer K, Seoka P, Raphala S. Characteristics of female sex workers and their 
HIV/AIDS/STI knowledge, attitudes and behaviour in semi-urban areas in South 
Africa. Curationis. 2004;27(1):4-11. 
130. Ramjee G, Kapiga S, Weiss S, Peterson L, Leburg C, Kelly C, et al. The value of site 
preparedness studies for future implementation of phase 2/IIb/III HIV prevention 
trials: experience from the HPTN 055 study. J Acquir Immune Defic Syndr. 
2008;47(1):93-100. 
131. Kharsany AB, Mlotshwa M, Frohlich JA, Yende Zuma N, Samsunder N, Abdool 
Karim SS, et al. HIV prevalence among high school learners - opportunities for 
schools-based HIV testing programmes and sexual reproductive health services. BMC 
Public Health. 2012;12:231. 
132. Abdool Karim Q, Kharsany AB, Frohlich JA, Werner L, Mlotshwa M, Madlala BT, 




imperative for their inclusion in HIV biomedical intervention trials. AIDS Behav. 
2012;16(7):1870-6. 
133. Nelson RM, Lewis LL, Struble K, Wood SF. Ethical and regulatory considerations 
for the inclusion of adolescents in HIV biomedical prevention research. J Acquir 














2. Approvals from the Postgraduate Education and Research 
















6. AIDS and Behavior – Instructions for Authors 
 
 






































































